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ABSTRACT 
The mechanism of ilvC expression in Escherichia coli was investigated. To 
carry out this work several different approaches were used. Firstly, sequencing of 
the ilvY2l43 allele which carries a mutation that makes ilvC expression constitu-
tive was completed. The location of the mutation was determined to be at the 5' 
end of the gene. It is a single base substitution ( G to A) at position 87 (counted 
from the transcription startpoint of ilvY). This results in a change of the codon 
for one amino acid. Glutamine in wild-type ilvY protein is replaced by lysine in 
the constitutive one. This substitution in the polypeptide of the upsilon protein 
(product of the ilv Y gene) was found to be solely responsible for making the UJr 
silon protein independent of the ilvC gene substrates (a-acetohydroxybutyrate or 
acetolactate) needed for ilvC induction. 
Two approaches were used. to determine the direction of ilv Y trancription. 
One of these employed a gene fusion technique which involves two DNA fragments 
of ilvY being fused separately to a promoterless lacZ gene, then monitoring the 
expression of lacZ. The other approach involved the labeling of the upsilon protein 
3s. 
with S· -methionine after expression of ilvY in a T7 RNA polymerase dependent 
promoter system. 
DNA-binding activity of upsilon protein was investigated. This was carried 
out in two assays, filter binding and gel retardation assays. These assays were 
employed to monitor purification of upsilon protein to near homogeneity. Upsilon 
protein has a subunit size of 35 kd and a native molecular weight of approximately 
211 kd, suggesting upsilon exists as a hexamer. 
Finally, in vitro activities of the upsilon protein were tested using transcriJr 
tional and coupled transcription-translation assays. Upsilon protein was shown to 
cause elevation of ilvC transcription. 
Two models for the action of the upsilon protein in regulating the transcription 
of the ilvYC are proposed. 
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CHAPTER 1 
INTRODUCTION 
Introduction 
1.1 Biosynthesis of isoleucine, valine and leucine in Escherichia coli. 
Isoleucine, valine and leucine are branched amino acids. They contain aliphatic, 
hydrophobic R groups. The synthesis of all three amino acids in bacteria starts 
from pyruvate. 
The biosynthesis of isolucine and valine has been studied extensively in E. coli 
and many other organisms, in which the biosynthetic pathways appear to be iden-
tified. This biosynthesis involves parallel pathways in which a series of bifunctional 
enzymes catalyze the conversion of two pyruvate molecules into valine and also 
the last four steps of isoleucine synthesis. 
The first step in this pathway is the conversion of threonine to a-ketobutyrate 
and this step is unique to isoleucine biosynthesis, (see Fig.1.1). It is catalyzed 
by the enzyme threonine deaminase. In E. coli, threonine deaminase has been 
purified and shown to have a native enzyme molecular weight of 212,000. It is a 
tetramer composed of four identical subunits of molecular weight 53,000 (Calhoun 
et al., 1973). 
The first step common to the biosynthesis of both isoleucine and valine is 
catalyzed by three bifunctional isozymes, acetohydroxy acid synthase (AHAS) I, 
II and III. These isozymes catalyze the condensation of two molecules of pyruvate 
with the formation of a-acetolactate the initial reaction in valine biosynthesis 
(Strassman et al., 1953). In addition, these isozymes also catalyze the formation 
of a-acetohydroxybutyrate by the condensation of a-keto butyric acid and pyruvate 
(Adelberg 1954; Strassman et al., 1954). (See Fig.l.1). 
The second enzyme in the parallel pathway is acetohydroxy acid isomerore-
1 
Fig. ( 1.1 ). 
Isoleucine-valine biosynthetic pathway including the metabolic intermediates and 
the enzymes catalyzing the various steps. 
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ductase which catalyzes the reductive isomerization of a-acetolactate to a-{3-
dihydroxyisovalerate and a-acetohydroxybutyrate to a, {3,dihydroxy-f3-methylvalerate 
(Umbarger et al., 1960). The reaction involves intramolecular migration of the R 
group from a to the f3 carbon (see Fig.l.1). It has been determined that acetohy-
droxy acid isomeoreductase has a molecular weight of 54,000 (Wek and Hatfield, 
1986). 
The subsequent reaction is the dehydration of the a-{3-dihydro:xy acids to 
yield the corresponding a-keto acids (see Fig.l.1). This is catalyzed by the en-
zyme dihydroxy acid dehydrase (Myers and Adelberg, 1954). This enzyme has a 
molecular weight of approximately 66,000 (Uzan et al., 1981; Gray et al., 1981). 
The last enzyme in the parallel pathways is transaminase B which catalyzes, 
the transamination of the a-keto acids forming the respective amino acids (Rud-
man and Meister, 1953). (See Fig.l.1). This enzyme was purified and character-
ized as a hexamer of identical subunits with a molecular weight 32,000 (Lee-Peng 
et al., 1979). 
The formation of leucine begins by a condensation of a-ketoisovalerate, which 
is the immediate precursor of valine, with acetyl coA, to yield a-isopropylmalic 
acid. The subsequent steps are similiar to those leading from citric acid to a-
ketoglutaric acid in the tricarboxylic acid cycle (see Fig.l.2). 
1.2 Feedback or end-product inhibition. 
This is a mechanism by which the activity of an enzyme is regulated by the 
steady state concentration of the product of the pathway. In bacteria, feedback 
inhibition is common in biosynthetic pathways as one of the mechanisms by which 
:flow through the pathway is regulated. In most multi-enzyme pathways, it is the 
first enzyme that is inhibited by the end-product. The first enzyme is usually 
2 
Fig. ( 1.2 ). 
Leucine biosynthetic pathway. 
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multimeric and contains separate binding sites for the substrate and regulatory 
effector, giving rise to allosteric reaction kinetics. 
1.3 Feedback inhibition for isoleucine, valine and leucine biosynthesis 
in E. coli. 
The conversion of threonine to isoleucine comprises an example of a multien-
zyme system. In this biosynthetic pathway, the first enzyme of the sequence, 
threonine deaminase, is strongly inhibited by the end-product of the sequence 
(isoleucine) when it is accumulated at high intracellular levels (Umbarger 1956). 
Accumulation of valine in the cell to a high level has the effect of inhibiting 
two of the three acetohydroxy acid synthase isozymes, AHAS I and AHAS III, 
that catalyze the first step of the parallel pathways (Guardiola et al., 1977). The 
third isozyme AHAS II is resistant to end-product inhibition by valine. 
Additionally, leucine is also involved in feedback inhibition mechanism, A a 
high level ofleucine inhibits the activity of AHAS III (Haughn et al., 1985). 
1.4 Regulation of gene expression. 
There are many mechanisms for genetic regulation in bacteria. All these 
mechanisms share the principle that a system is expressed only when it is needed. 
This type of on and off activity is carried out by regulating transcription. 
Regulation of transcription in bacteria exists in several patterns and these 
patterns depend on the type of metabolic activity of the system being regulated. 
For example, in a degradative system (catabolic pathway), the concentration of 
the initial substrate in the sequence often determines whether the enzymes in 
the pathway are synthesized. In an anabolic pathway the final product is the 
3 
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regulatory substance. On the other hand, in a system in which a single type of 
protein molecule is translated from a monocistronic mRN A, the protein may be 
autoregulated. 
There are two major catagories of molecular mechanism for genetic regulation 
called negative and positive regulation. In negative regulation the transcription is 
turned off by an inhibitor protein present in the cell and an inducer (anti-inhibitor) 
is needed to turn the system on. In positive regulation, an activator protein is 
required to stimulate transcription. There are some genetic systems which are 
both positively and negatively regulated. 
1.5 The lactose operon. 
Lactose is a sugar that can serve as a carbon source for metabolism. A mecha-
nism for the regulation of the lactose genes, the lac operon, was proposed by Jacob 
and Monod (1961). The lac operon includes three structural genes lacZ, lacY and 
lacA which encode ,8-galactosidase, permease and acetylase respectively. There is 
a operator region (lacO), recognized by a repressor protein (encoded by the lac/ 
gene), and a promoter region (lacP) to which RNA polymerase attaches before 
transcription of the structural genes. Two states of the lac operon are established, 
an off state (in the absence of lactose) and on state (in the presence of lactose). In 
the case of wild-type E. coli growing in the absence of lactose, RNA polymerase 
binds to the repressor gene (lac!) and transcribes the I gene. The synthesis of 
the repressor is constitutive. The repressor binds with high affinity to a particular 
base-pair sequence in the operator. When the repressor is bound to the operator, 
RNA polmerase can not bind to the operon's promoter and hence transcription 
of the structural genes will not occur. There is in fact a low level of transcrip-
tion of the structural genes, that results in the presence of a few molecules of 
4 
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each structural protein. This is because repressor protein is in equilibrium bound 
and unbound forms. This occasionally allows access of RNA polymerase to the 
promoter. When wild-type E. coli is grown in the presence of lactose as the sole 
carbon source, the cells must make large amounts of the lactose utilization en-
zymes to grow. Some of the lactose transported into the cells is converted by the 
few existing molecules of ,8-galactosidase into allolactose which in turn induces 
the production of the lac operon enzymes (thus allolactose, not lactose is the ac-
tual inducer of the lac operon). In addition to having a recognition site for the 
lac operator the lac repressor protein also has a recognition site for allolactose. 
When allolactose binds to the repressor it causes a conformational change in the 
repressor. As a result, the repressor losses its affinity for the lac operator and 
dissociated from it (free repressor protein is also altered so that it can not bind to 
the operator). In the absence of repressor, RNA polymerase is now able to bind 
to the promoter and initiate the transcription of a single polycistronic mRN A. 
1.6 Catabolite repression. 
Glucose, being the prefered carbon source, plays an important role in the 
regulation of expression of inducible enzymes. In this regulation the rate of the 
synthesis of inducible enzymes is reduced to about a third when bacteria are 
grown in a medium containing glucose compared with the same strain growing in a 
medium without glucose. The reason for this reduction is that glucose metabolism 
exerts an effect in lowering the level of 3
1 
-5' -cyclic AMP in the cell (Makman and 
Sutherland, 1965). Cyclic AMP is essential for expression of the lac operon. A 
protein called the catabolite activator protein (CAP) forms a complex with cAMP. 
It is now established that the cAMP-CAP complex binds to a base sequence in the 
lac promoter region. This binding is a prerequisite for the correct RNA polymerase 
binding. Hence, the cAMP-CAP complex is a positive regulator. The cyclic AMP-
5 
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CAP complex acts not only on the lac operon but also needed for the experession 
of many inducible operons. 
Thus, the lac operon responds to both positive and negative control. 
1. 7 The Arabinose operon. 
Arabinose is a sugar which can serve as a carbon source for metabolism. In 
E. coli the arabinose operon includes three structural genes, araB, araA and araD 
which form an operon. Adjacent to these there is a complex promoter region and 
a regulatory gene araC. Additionally, there are other unlinked genes araE and 
araF which are necessary for the transport of arabinose across the cell membrane. 
The arabinose operon is another inducible system and the inducer is arabinose 
itself. The lac operon is under the control of independent positive and negative 
systems, whereas, the arabinose operon is under dual positive and negative control 
mediated by the same protein encoded by the araC gene (Englesberg 1971; Lee 
1978). This double action of araC protein was explained by proposing that there 
are two isomeric forms of the protein, inducing and repressing form. In the absence 
of arabinose in the media, the repressor form of araC protein predominates but 
when arabinose is present it binds to the araC protein causing a change to the 
activator form.The ara system is also subject to catabolite repression. 
The synthesis of araC protein is also regulated. It is one of a class of proteins 
that regulate their own synthesis (autogenous regulation). It acts as a negative 
regulator at the promoter of the araC gene. Thus, the expression of araC is 
repressed by its own product and stimulated by the CAP system ( Casadaban 
1976b). 
6 
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1.8 The Galactose operon. 
Galactose is a sugar and has two roles in cellular metabolism. It serves as 
a carbon source and also in the synthesis of cell wall components. This operon 
includes three structural genes, galK, galT and galE, an operator and a promoter 
region. The repressor gene galR is not linked to the structural genes. The idea 
of existance of the two overlapping promoters in this operon was concluded from 
in vitro transcription studies with the E. coli gal operon. One promoter (Pl) 
functions only in the presence of the cyclic AMP-receptor protein ( cAMP-CRP) 
whereas the other promoter (P2) operates without these factors and is inhibited 
by them (Musso et al., 1977). 
Four gal operon promoter mutants have been isolated by Busby (1982). The 
biochemical analysis of these mutants argues strongly for the existance of two 
functional promoters in vivo and their different regulation. These mutants were 
classified into two classes. One class of mutant has the property that high level 
synthesis of the enzymes fails to occur when glucose is present. The other mutant 
class is defective in enzyme synthesis when glucose is absent. Glucose fails to 
inhibit the induction of the gal operon because one of the promoters does not 
require cAMP-CAP and thus remains active even in the presence of glucose. 
The start points 81 and 82 for the two gal mRNA molecules differ functionally. 
Transcription from 81 occurs when glucose is absent because it is dependent upon 
cAMP-CAP. While transcription from the 82 occurs when glucose is present. 
The mechanism by which cAMP-CAP stimulates 81 transcription and inhibits 82 
transcription is not clearly known. It is thought that stimulation at the 81 site 
occurs in a way that is similar to that in the lac operon. 
The mechanism of action of the gal repressor is also obscure. It is thought that 
the gal repressor binds to the cAMP-CAP binding site and blocks the the initation 
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at 81 in one of two ways. Either by interfering with the binding of cAMP-CAP 
to DNA or by altering the stimulatory effect of cAMP-CAP on RNA polymerase 
binding. Repression at 82 seems to have a totally different mechanism. Initation 
still occurs at 82 if the gal repressor is present but transcription is terminated 
10-20 bases downstream, how this happens is not known. 
1.9 The tryptophan operon (A biosynthetic system). 
Tryptophan is synthesized by a group of five enzymes encoded by the trp 
operon consisting of trpE, trpD, trpC trpB and trpA. The first gene to be 
transcribed is trpE. Adjacent to this are the promoter, the operator, the leader 
and the attenutor regions. 
cs. 
Regulation of tryptophan biosynthesis were thought to be carried out solely by 
the repressor-operator control system of gene expression and feedback inhibition 
of enzyme activity. Tryptophan acts as a corepressor it combines with a repressor 
protein and together they bind to the operator that precedes the trp operon and 
thus represses the synthesis of trp mRNA. 
The discovery of attenuation adds an additional level of control to the operon. 
Attenuation is a mechanism involved in the control of several amino acid biosyn-
thetic operons and was first described in the trp operon of E. coli. This system 
is effected by premature termination of transcription before it reaches the first 
structural gene and regulation of the frequency of this termination is by the con-
centration of relevant amino acids. 
The trp operon initiates transcription 162 base pairs before the start codon 
of the first structural gene trpE. This segment of mRNA is called the leader, the 
translation of the leader in vivo to a small peptide was established (Miozzari and 
Yanofsky, 1978). Within this leader there is a sequence of bases (123 through 150) 
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which if deleted, cause a sixfold increase in the synthesis of trp enzymes either 
in derepressed cells or constitutive mutants. Thus, this sequence of bases must 
have a regulatory activity. It has been established that transcription termination 
occurs in this region at a site called the attenuator. The attenuator itself consists 
of a G-C rich stem and loop structure followed by a stretch of poly-U residues. 
The formation of this G-C rich structure causes transcription termination. 
Yanofsky et al., (1978) proposed a model for attenuation which was modified 
by Keller and Calvo (1979) using the trp operon as an example. The regulation of 
transcription termination is concerned with allowing or preventing the G-C rich 
terminator to form. When the terminator fails to form, transcription will continue 
through the poly U stretch into the structural genes. Preceeding the terminator 
there are several overlapping stem and loop structures. The structure overlapping 
the terminator is called the pre-emptor, if it is allowed to form it will prevent 
the formation of the terminator allowing transcription to continue. Preceeding 
the pre-emptor is another structure called the protector, which will allow the 
formation of the terminator. Such structures form in order of transcription, thus 
the protector will form first preventing pre-emptor formation and thus allowing 
the formation of the terminator (see Fig.1.3). Overlapping the protector is the 
coding sequence for a small (14 amino acid residues) polypeptide, called the leader 
peptide. The leader polypeptide has an interesting feature namely, at positions 
10 and 11 there are two adjacent tryptophan codons. 
The attenuation control system works as follows, in the presence of excess 
tryptophan there is also a large amount of the corresponding charged tRNA thus 
the leader peptide will be rapidly synthesized. As transcription and translation are 
coupled in bacteria, the ribosome will follow closely behind the RNA polymerase, 
translating the message as soon as it is formed. When the ribosome reaches the 
stop codon of the leader peptide, all of protector stem and loop can form, whereas 
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A. The important features of leader mRNA in the tryptophan operon. Regions 
involved in stem and loop formation are:- Hatched area is the protector stem. 
Closed box is the pre-emptor stem. Open box is the terminator stem. While 
x:xxxxxx: refers to the positions of the tryptophan regulatory codons. 
B. Effect of various growth conditions on the formation of secondary structures 
of the trp leader transcript. 
2 & 3 under excess tryptophan. 4 & 5 under limiting amounts of tryptophan. 
After M. D. Watson (1981). 
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the pre-emptor cannot, the formation of protector stem and loop will result in 
formation of a terminator (see Fig.1.3). On the other hand, when tryptophan is 
limiting there will be insufficient charged tRNA to complete the translation of the 
leader peptide. The ribosome will thus stall at the tandem tryptophan codons and 
prevent formation of the protector. Thus, the first secondary structure formed 
will be the pre-emptor. As the result of pre-emptor formation it will prevent 
subsequent formation of the terminator. In the absence of the terminator the 
RNA polymerase will transcribe through the attenuator into the structural genes. 
1.10 Gene-enzyme relationships in the isoleucine-valine system of E. coli. 
Threonine deaminase, the first enzyme in isoleucine biosynthesis, is encoded 
by the ilvA gene. The three AHAS isozymes are encoded by ilvB (AHAS I), ilvG 
(AHAS II) and ilvH (AHAS III). 
In in vitro complementation studies by DeFelice et al., (1974), it has been 
suggested that the enzyme AHAS III composed of a regulatory subunit (encoded 
by ilvH) and a catalytic subunit (encoded by ilvl). Similarly, AHAS II has a large 
(ilvG) and a small (ilvM) subunit, as does AHAS I (ilvB and ilvN). AHAS I and 
AHAS III are sensitive to valine feedback inhibition, whereas AHAS II is resis-
tant to end-product inhibition by valine. The original E. coli K-12 strains express 
only AHAS I and AHAS III activities because of a naturally occuring frameshift 
mutation in ilvG. (Favre et al., 1976; Lawther et al., 1982). This results in 
the well described valine-sensitivity of wild-type E. coli strains. Later, sponta-
neous mutations have been isolated in the ilvG gene which remove this frameshift 
site. These were originally called ilvo- mutations (Ramakrishman and Adel-
berg, 1965). These mutations result in expression of AHAS II and confer valine 
resistance to the bacteria and result in a higher expression of the ilvGM EDA 
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operon. 
The second step in the parallel pathway is catalyzed by acetohydroxy acid 
isomeroreductase which encoded by the ilvC gene. 
Dihydroxy dehydrase is the third enzyme catalyzing the third reaction in the 
parallel pathway. This enzyme is encoded by the ilvD gene. 
The last gene involved in the above biosynthesis is ilvE which encodes the 
enzyme transaminase B. 
1.11 Physical Maps of the ilv genes. 
The physical location of the ilvGM EDAC genes on the restriction map of the 
ilv region of E. coli K-12 was determined by McCorkle et al., (1978) by two meth-
ods. Firstly, heteroduplex and endonuclease cleavage analysis of hybrid phages 
carrying genetically defined parts of the ilv cluster. Secondly, complementation 
analysis and enzyme assays to determine ilv genes expression from hybrid plas-
mids containing DNA restriction fragments of the transducing phage .X80dilv. 
The results obtained by McCorkle et al., (1978) revealed the location of the 
ilvEDA transcriptional unit and ilvC. The direction oftranscription was deduced 
for both units. The exact location of ilvG M could not be determined in their 
studies. Subrahm.anyan et al., (1980) eventually showed that ilvG is adjacent to 
ilvE and forms part of the same operon. 
Thus, from above description, it can be concluded that the major transcrip-
tional unit of the ilv cluster is the ilvGM EDA operon. This operon encodes four 
of the five enzymes involved in the parallel pathway of isoleucine-valine biosyn-
thesis. (See Fig.l.4). 
The location of the ilvY gene is between the ilvA and ilvC genes. This was 
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The major ilv cluster. The position of the structural genes are demonstrated 
within this cluster. The size of these genes are drawn to scale. Arrows represent 
the direction of transcription within this cluster. 
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shown by the fact that only plasmids containing the entire region between ilvA 
and ilvC were able to restore to strain CU827, which deleted for ilvDAYC, the 
ability to induce ilvC expression (Watson et al., 1979). 
The ilvGM EDAYC cluster is located at 85 minutes on the E. coli linkage 
and the ilvBN and ilvl H are located at 82 and 2 minutes respectively on the 
linkage map (Bachmann 1983). 
1.12 Regulation of the ilv operons. 
Genes and operons concerned with amino acid biosynthesis are generally regu-
lated by two mechanisms in E. coli and other enteric bacteria. The first mechanism 
involves negative control and repression of transcription by an operator-repressor 
system while the second one is attenuation. In E. coli K-12, the genes and operons 
involved in the biosynthesis of isoleucine-valine are generally regulated by atten-
uation, however, there are exceptions to this outlined in the following sections. 
1.13 Regulation of ilvBN operon. 
The ilvBN operon is regulated both by catabolite repression (Freundlich 1977; 
Sutton and Freundlich, 1980), who carried out a number of in vivo experiments 
that suggest that the ilvBN operon is positively regulated by cAMP-CAP, and 
attenuation (Friden et al., 1982; Hauser and Hatfield, 1983). 
Friden et al., (1982) found that cyclic AMP was involved in the control of the 
ilvBN operon via the usual complex. The bound cAMP-CAP (catabolite activa-
tor protein) protects an area of 26 nuleotides positioned around the -70 region of 
c. 
the ilvBN promoter. The above in vitro studies showed that transcription from 
ilvB promoter is strongly increased by addition of cyclic AMP and CAP, thus 
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confirming that ilvB is regulated by cyclic AMP. 
The second mechanism of regulation is through attenuation in a manner sim-
ilar to that proposed for the regulation of the tryptophan operon. Friden et al., 
(1982) determined the DNA sequences of the promoter-regulatory region of the 
ilvBN operon of E. coli. A sequence starting at the ATG at position 36 and 
ending at position TAG at position 134 that could code for a polypeptide. This 
potential leader polypeptide contains 32 amino acids, 9 of which are valine at 
positions 19 through 28 and 3 leucine residues at positions 6, 10 and 11. These 
two amino acids are involved in the multivalent control of the ilvBN operon. 
Five stem and loop structures can be potentionally formed by the ilvB leader 
mRN A. So, in this regulation more stem and loop structures can be formed than 
that of the trp leader attenuation. The initial stem and loop structure (pre-
emptor defender) forms prior to and precludes the protector and thus allow the 
pre-emptor to form while the other extra stem and loop structure (protector de-
fender) precludes the pre-emptor defender and permits protector formation. Thus, 
the function of these protector and pre-emptor defenders is to safeguard the for-
mation of protector and pre-emptor respectively. Without these initial structures 
the tandem Leu codons of the leader peptide could not participate in regula-
tion because these codons are situated too far upstream from the protector and 
the Val regulatory codons. A ribosome stalls at the tandem Leu codons when 
there is a shortage of leucyl-tRN A Leu and this stalling prevents the formation 
of the protector defender. Thus, pre-emptor defender and pre-emptor form and 
preclude termination which results in transcription readthrough and increased ex-
pression ofthe ilvB operon (see Fig.l.5). On the other hand during a limitation of 
valyl-tRNAVal, stalling of ribosomes at the multiple tandem Val codons prevents 
formation of the protector itself allowing the pre-emptor to form and so again 
precluding transcription termination (see Fig.l.5). The model proposed above 
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The alternative secondary structures of the leader mRNA in the ilvBN operon 
and the effects of growth conditions on formation of these structures . 
. A. Possible secondary structures in the absence of ribosome. 
B. Excess leucine and valine which cause transcription termination. 
C. limiting Valyl-tRNA. 
D. limiting leucyl-tRNA. Both conditions inC and D cause transcription readthrough. 
After Friden, P. et al., (1982). 
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also predicts that ribosomes stalling at the 3rd, 4th or 5th Val codons results in 
the partial relief of attenuation. It is suprising that the 1st and 2nd Val do not 
participate in regulation. 
1.14 Regulation of the ilvGM EDA operon. 
The ilvGM EDA operon is regulated by a multivalent mechanism (Lawther 
and Hatfield, 1980; Adams et al., 1985). The expression of enzymes encoded by 
the above operon is inhibited by the presence of all three branched amino acids, 
isoleucine, leucine and valine. When the growth rate of the cell is limited by the 
availability of any one of these amino acids the rate of synthesis of these enzymes 
increases. On the other hand, there is no direct evidence for the involvment of a 
repressor in the regulation of this operon. 
Lawther and Hatfield (1980) determined and characterized the regulatory re-
gion for the ilvG M EDA operon of E. coli K-12. This region includes a tran-
scription promoter, 186 nucleotide leader RNA encoding a 32 residue polypeptide 
containing 5 isoleucine, 5 leucine and 6 valine codons and a transcription termi-
nation site preceeding the first structural gene. Based on the secondary structure 
prediction of the nucleotide sequence of the leader RNA, it is proposed that the 
leader RNA can form alternative structures which control the level of transcrip-
tion into the structural genes of this operon. Three stem and loop structures can 
be formed by the leader RNA. 
Lawther and Hatfield (1980) proposed a model for the multivalent attenuation 
of the ilvGEDA operon on the basis of analys.ing the possible secondary struc-
tures of the its leader RNA. This model proposes that under in vivo conditions of 
coupled transcription-translation, a ribosome stalling at initial tandem codons for 
leucine at positions 4 and 5 results in disruption of the base pairing between re-
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I I 
gions 1A and the 3 half of region 2. This free 3 half of region 2 can now base pair 
with complementary sequences in region 5 of the stem-loop terminator structure. 
This event destabilizes the top half of the terminator and results in prevention of 
transcription termination (see Fig.1.6B). 
Stalling the ribosome at the tandem valine codons at positions 11 and 12 and 
the three valine codons followed by the three isoleucine codons at positions 15 
I 
through 20 disrupt the base pairing between regions 1B and the 5 half of region 
2. This disruption results in inhibition of the formation of the bottom half of 
the stem-loop terminator structure and as a result transcription of the structural 
genes occurs (see Fig.1.6C). A ribosome stalling at these latter codons exposes 
I 
the 5 end of the leader message sufficiently to load another ribosome. From 
Fig.1.6D it is clear that the loading of additional ribosomes allows both halves 
of region 2 to base pair with region 5 and result in complete disruption of the 
terminator structure. To explain the observation that the ilvGM EDA operon is 
deattenuated by isoleucine limitation, the stalling of a ribosome at the last two 
isoleucine codons allows the attachment of another ribosome. This is necessary 
because ifthere was no ribosome at region 1A then the entire stem-loop terminator 
structure would form. 
Recently, the necessity for transcription of certain sequences of DNA more 
than 100 bp upstream of the transcription initiation site of the ilvGM EDA operon 
has been reported. This observation suggests that there may be a new class of 
promoters in enteric bacteria and that regulation of this operon cannot be solely 
explained by attenuation (Haughn et al., 1985). 
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The possible secondary structures of the leader mRNA in the ilvGEDA operon 
and the effect of ribosome positioning at different regulatory codons. Thick bars 
represent base-paired regions. 
A. No translation. 
B. Ribosome paused at a tandem leucine codons. 
C. Ribosome paused at tandem valine or isoleucine codons. 
D. Ribosome paused at tandem isoleucine codons with attachment of the second 
ribosome. 
After Lawther & Hatfield (1980). 
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1.15 Regulation of the ilvl H operon. 
The expression of the ilvl H operon is negatively controlled by leucine at the 
level of transcription. The mechanism by which leucine represses the transcription 
of the il vI H operon remains unclear. Haughn et al., ( 1985) studied the mechanism 
by which ilvl H operon is regulated. Their results reveal that sequences more 
than 200 bp upstream of the presumed site of transcription initation appear to 
be neccessary for optimal expression of ilvl H operon. Transcription initiated 
near position -30 bp was repressed by leucine only if these upstream sequences 
were present. This appears to rule out a mechanism of regulation based solely on 
attenuation. 
1.16 Regulation of the ilvYC system. 
Arlin et al., (1969) concentrated their studies on the regulation of expression of 
the ilvC gene. They produced evidence which strongly supports the view that ace-
tohydroxy acid isom~reductase is induced directly or indirectly by its substrate. 
This finding is quite in accord with the fact that this enzyme is not controlled by 
either the operator locus that controls the three structural genes for the enzymes 
transaminase B, dehydrase and threonine deaminase or by the oplator locus that 
controls the genes governing the AHAS enzymes (Ramakrishnan and Adelberg, 
1965). 
Another attempt to study the mechanism of ilvC induction in E. coli strain 
K-12 was carried out by Wild et al., (1977) who developed an in vitro protein 
synthesizing system using the DNA from a plaque forming phage carrying an 
ilvC::lacZ fusion as a template for ,8-galactosidase synthesis. They stated that 
unless the ilvC inducer ( acetohydroxybutyrate or acetolactate) was present during 
the transcription period, the level of ,8-galactosidase formed was very low. 
16 
Introduction 
The characterization of ilvC induction has been described in more detail by 
Watson et al., (1979). They identified the existance of a regulatory gene, desig-
nated ilvY, which codes for a positive control factor necessary for ilvC induction. 
The product of the ilv Y gene is called the upsilon protein. The experiments of 
Watson et al., involved, firstly, the construction of an ilvC::lacZ fusion using the 
method of Casadaban (1976a). This fusion puts lacZ expression under the con-
trol of the ilvC promoter. Secondly, the preparation of S-30 extracts from several 
strains of E. coli including CU827 which carries the ilvDACll5 deletion. S-30 
extracts prepared from the above strains were examined for their ability to in-
duce the ilvC directed lacZ expression in the presence of acetohydroxybutyrate. 
The results obtained from these experiments revealed that only the wild-type S-
30 extracts were competent in ilvC directed ,8-galactosidase synthesis. The S-30 
extracts prepared from the strains carrying the deletions failed to show any lacZ 
expression although acetohydroxybutyrate was available. Hence, the two deleted 
strains CU827 and CU838 lack a factor needed for ilvC induction. The gene for 
this factor deleted in the above strains, was designated ilvY. When the deleted 
strains were transformed with plasmids carrying parts of ilvDAC region the in-
duction of ilvC was restored. Thus, the induction of ilvC is under the positive 
control of the product. Genetic analysis of ilv yc mutations constitutive for ilvC 
expression confirms this prediction and map position (Biel and Umbarger, 1980). 
In E. coli the existance of an inducible gene under positive control is unique 
for one involved in amino acid biosynthesis, which is more usually controlled by 
repressible negative control and /or attenuation. 
A model has been proposed for the regulation of the ilvYC system (Wek 
and Hatfield, 1986). This model proposes that the ilvY-encoded activator pro-
tein, upsilon, in the presence of either acetohydroxybutyrate or acetolactate, the 
substrates for the ilvC encoded acetohydroxy acid isomeroreductase, bind to an 
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operator site located between ilvY and ilvC and activate ilvC transcription. The 
proposed operator site is a sequence that is conserved between both E. coli and 
S. typhimurium. 
Assay methods for identification and charcterization of DNA binding 
proteins. 
1.17 The Filter binding assay. 
Several techniques have been employed to identify and characterize DNA bind-
ing proteins. These assays in general exploit the specific binding of these proteins 
to certain DNA sequences. The filter binding assay is one such method which 
is at present widely used (Riggs et al., 1970). This assay depends on the fact 
that proteins have the ability to bind to nitrocellulose filters. DNA molecules 
rarely bind to nitrocellulose filters under physiological conditions. However, when 
a particular DNA binding protein is present with its target DNA, it will cause 
retention of the DNA on the nitrocellulose filter. 
Many protein-nucleic acids interactions have been studied utilizing a mem-
brane filter binding technique, of these, aminoacyl tRNA synthase-tRNA (Yarus 
and Berg, 1967), lac repressor-lacO (Riggs et al., 1968) and mRNA-ribosome 
(Nirenberg and Leder, 1964), interactions are good examples. 
Due to some weaknessess in the filter binding assay, complete retention can-
not be expected. These weaknessess can be explained by three possible reasons. 
Firstly, some of the DNA molecules are broken and thus they will not possess 
an intact binding site. Secondly, washing, which is usually done after applying 
the binding mixture to the nitrocellulose filter, causes, loss or dissociated of some 
complexes. Lastly, the binding of the protein itself may not be 100% efficient. 
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The second weakness prevents this technique from providing an accurate analysis 
of the composition of the binding reaction product. 
1.18 The Gel retardation assay. 
Regulatory proteins have the ability to bind to a particular DNA sequence. 
This protein-DNA binding requires more characterization and analysis. In addi-
tion to the filter binding assay, the gel retardation assay is a powerful method for 
studying DNA-protein interactions. The principle of this technique relies on the 
fact that a protein bound to a particular DNA sequence has a greater molecular 
mass than either of the two components alone. The product of this interaction is 
analyised on either an agarose or polyacrylamide gel electrophoresed in low ionic 
strength buffer which stabilize the complex against dissociation. The greater mass 
of the complex results in a lower mobility compared with the migration of the same 
DNA fragment without bound protein. 
This technique was first introduced by Fried and Crothers (1981) who char-
terized the interaction of E. coli lac repressor with DNA restriction fragments 
containing specific repressor binding sites. The protein is mixed with one or more 
DNA fragments and protein-DNA complexes are resolved as discrete bands by 
polyacrylamide gel electrophoresis, mobilities decrease as a function of the num-
ber of proteins bound to a given DNA fragment. 
Garner and Revzin (1981) applied this assay to the study of the E. coli lactose 
operon regulatory system. They showed that the CAP-cAMP complex forms a 
long-lived complex with wild-type lac promoters. Additionally, this gel retardation 
assay has been used by Zerbib et al., (1987) to identify the specificity of IS1 DNA 
binding of particular protein in the cell extracts from InsA overproducers. They 
show that the extracts display a DNA binding activity specific for the ends of IS1 
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only. This activity was identified as the InsA protein. It is probable that the InsA 
protein recognizes and binds sequences within the inverted repeats which reside 
at the ends of IS 1. 
1.19 Gene fusions as a tool for genetic analysis. 
Fusions of the E. coli lacZ gene to other genes produces a powerful tool for 
molecular biology due to the stability of ,8-galactosidase and the ease by which it 
can be assayed (Bassford et al., 1978). Two types of fusions have been used, the 
first, a transcriptional fusion, is where the operon of interest is fused to a lacZ gene 
lacking its own promoter but containing its own translation start site. The second 
type is a translational fusion, in which a lacZ gene lacking both transcription 
and translation initation signals is fused in frame to the coding sequence of the 
target gene. Both types of fusion mentioned above express the lacZ gene from 
the promoter of the target gene and allow the genetic and biochemical methods 
developed for the lac system to be used to study the regulation of any gene. 
Additionally, the protein fusion, produced by the translational fusion, pro-
duces a hybrid protein whose N terminus is encoded by the target gene and is 
fused to an enzymatically active ,8-galactosidase. These hybrid proteins have ad-
ditional applications beyond the study of gene expression. For instance, hybrid 
proteins can be used to raise antibodies against the exogenously encoded N ter-
minus which in turn can be used to identify the product of the wild type target 
gene. Such, hybrid ,8-galactosidase proteins have been useful in the study of pro-
tein function. 
As a result of the development of gene fusion technology much effort has 
been spent on constructing plasmids which can be used as cloning vectors which 
directly fuse a target gene to lacZ. Two classes of these cloning vectors have been 
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created. The first class contains various restriction enzyme cleavage sites in a 
variety of translational reading frames adjacent to a promoterless lacZ gene. The 
second class retains an active lac promoter and lacZ translational initation region 
which can direct hybrid protein synthesis from DNA fragments that do not have 
functional promoters or translation initiation sequences (Shapira et al., 1983). 
1.20 The T7 expression system. 
Sometimes it is necessary to express particular genes to a high level because 
their products normally comprise only a small fraction of total bacterial protein. 
For example, regulatory genes which encode regulatory proteins are normally ex-
pressed at only low levels. 
Studier and Moffatt (1986) developed a gene expression system based on the 
bacteriophage T7 RNA Polymerase. They demonstrated that T7 RNA Poly-
merase is highly selective for its own promoter which does not occur naturally in 
E. coli. Transcription by T7 RNA Polymerase is very active. A relatively small 
amount of T7 RNA Polymerase, provided from a cloned copy of T7 gene 1, is suf-
ficient to transcribe a gene placed next to a T7 RNA polymerase specific promoter 
and this transcription occurs at high level. T7 RNA polymerase and E. coli RNA 
polymerase recognize different promoter sequences (Dunn and Studier, 1983; Haw-
ley and McClure, 1983). Thus, it is possible to clone a gene under the control of 
T7 RNA polymerase without effecting its expression by E. coli RNA polymerase. 
The antibiotic rifamp·cin can be used to establish the high level expression of 
a particular gene by T7 RNA polymerase due to its inactivation of E. coli RNA 
Polymerase. Thus, all transcription in the cell will be due to T7 RNA polymerase. 
The rifampcin is useful in reducing the background in a pulse-labelling experiment 
to label either specific RNA or protein whose synthesis is under the control of T7 
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RNA Polymerase. 
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2.1 Materials. 
MATERIALS AND METHODS 
CHAPTER 2 
MATERIALS AND METHODS 
All chemicals and reagents were purchased from Sigma except following, the 
restriction enzymes, modifying enzymes, X-gal (5-bromo-4-chloro-3-indolyl-.8-D-
galactoside) and IPTG (isopropylthiogalactoside) were from Northumbria Biolog-
ical Ltd., Cramlington, Northumberland. 
Agarose and low melting point agarose were purchased from GIBCO /BRL, Pais-
ley, Scotland and from ICN biochemical Ltd., High Wycombe, respectively. 
All the radioactive isotopes were purchased from Amersham International p.l.c., 
Amersham, Bucks. 
Nitrocellulose filters were from Schleicher and Schuell, Dassel. 
3MM paper was from Whatman Ltd., Maidstone, Kent. 
Sephadex G-25, G-50 and G-200 were from Pharmacia Fine Chemicals, Uppsala, 
Sweden. 
Bacto agar was from Difco Labs, Detroit, Michigan, U.S.A. 
BBL trypticase peptone was from Becton Dickinson and Co, Cockeysville, M.D., 
U.S.A. 
Caesium chloride and sodium chloride were from Kochlight Ltd., Haverhill, Suf-
folk. 
High vaccum grease was from Dow Corning S.A., Seneffe, Belgium. 
Polaroid 667 film was from Polaroid (U.K.) Ltd., St Albans, Hertfordshire. 
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2.2 Preparation of media. 
Luria broth 
lOg Bacto-Tryptone 
5g Bacto-Yeast extract 
5g NaCl 
1 Litre H20 
2x YT media 
16g Bacto-Tryptone 
lOg Bacto-Yeast-Extract 
5g NaCl 
1 Litre H20 
L-agar plates 
15g Bacto-agar per 1 litre of L-broth. 
MacConkey-lactose agar plates 
MATERIALS AND METHODS 
40g MacConkey agar was dissolved in 1 litre water by heating to boiling followed 
by addition of lOg lactose then autoclaved. 
Top-agar 
It has the same composition of L-agar plates except that the agar is 0.66%. 
M9 Media 
0.6g N a2HP04 
0.3g KH2P04 
50mg NaCl 
O.lg NH4Cl 
90 ml H20. 
These components were mixed, autoclaved, cooled to room temperature then 
0.2 ml 1 M MgS04 
1.0 ml 20% Glucose 
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0.01 ml 1 M CaCl2 
H20 to 100 ml. 
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2.3 Preparation of the buffers and common solutions used in this work. 
lOx Alec's buffer 
Tris 44.4g 
EDTA 3.7g 
Ethidium Bromide 0.5 ml (10 mg/ml) 
pH 7. 7 with glacial acetic acid 
H20 to 1 litre. 
lOx Binding buffer 
Tris-HCl pH 7.4 500 mM 
KCllOO mM 
EDTA 10 mM 
,8-meracaptoethanol 10 mM 
MgCl2 70 mM 
CaCl2 30 mM 
To 1 ml by sterile water. 
lOx TBE buffer 
Tris 12l.lg 
Boric acid 51.35g 
EDTA 3.72g 
H20 to 1 litre. 
lOx PAGE buffer 
Glycine 14lg 
Tris 30g 
SDS lOg 
25 
H20 to 1 litre. 
2x Sample buffer 
Tris-HCl pH 6.8 0.2 M 
SDS 0.2% 
Sucrose 10%. 
Prehybridization buffer 
2ox sse 18 m1 
0.5% SDS 3 ml 
5x Denhardt's solution 6 ml 
MATERIALS AND METHODS 
Denatured salmon sperm DNA (100 JJ-g/ml) 200 JJ-1 
H20 to 60 ml. 
Hybridization buffer 
This has the same components as prehybridization buffer in addition to 0.01 M 
EDTA and 1 ml of radioactive probe. 
20x sse solution 
NaC1175.3g 
Trisodium citrate 88.2g 
Dissolved in 800 ml water and the pH adjusted to 7.0 with 10 M NaOH and the 
volume made up to 1 litre. 
5x Denhardt's solution 
Ficoll 400 0.5g 
PolyvinylPyrrolidone 0.5g 
BSA 0.5g 
Dissolved in 100 ml sterile water and stored at -20°C. 
Gel stain solution 
Coomassie Brillant Blue 0.2 % 
Methanol 50 % 
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Glacial acetic acid 7%. 
Gel destaining solution 
Methanol 40% 
Glacial acetic acid 10%. 
TE buffer pH 8.0 
Tris-HCl pH 8.0 10 mM 
EDTA pH 8.0 1 mM. 
TEN buffer 
Tris-HCl pH 8.0 10 mM 
EDTA pH 8.0 1 mM 
NaCl10 mM. 
TENS buffer 
Tris-HCl pH 8.0 10 mM 
EDTA pH 8.0 1 mM 
NaC110 mM 
SDS 0.1%. 
Transformation buffer 
CaCh 50 mM 
Tris-HCl pH 8.0 10 mM. 
lOx Transcription buffer 
MgCl2 100 mM 
Tris-HCl pH 8.0 0.4 M 
EDTA pH 8.0 10 mM 
,8-meracaptoethanol 60 mM 
BSA 5 mg/ml 
Glycerol 2% 
DTT 30 J.LM. 
MATERIALS AND METHODS 
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Nucleotide mixture solution 
15 j.tl of 10 mM of ATP, GTP, CTP and UTP were mixed and the volume com-
pleted to 100 J.tl by sterile water. 
lOx Calf intestinal phosphatase ( CIP) buffer 
Tris-HCl pH 9.0 0.5 M 
MgCl2 10 mM 
ZnCl2 1 mM 
Spermidine 10 mM. 
lOx Ligation buffer 
Tris-HCl pH 7.6 0.66 M 
MgCh 50 mM 
DTT 50 mM 
ATP 10 mM. 
lOx Blunt end-kinase buffer 
Tris-HCl pH 9.5 0.5 M 
MgCh 0.1 M 
DTT 50 mM 
Glycerol 50%. 
lOx T4 kinase buffer 
Tris-HCl pH 7.6 0.5 M 
MgCl2 0.1 M 
DTT 50 mM 
Spermidine 1 mM 
EDTA 1 mM. 
lOx nick translation buffer 
Tris-HCl pH 7.2 0.5 M 
MgCl2 0.1 M 
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DTT 1 mM 
BSA 500 J.Lg/ mi. 
Bendict's Reagent. 
e. 
Composed of two solutions:-
SoLI 
Trisodium citrate 173g 
MATERIALS AND METHODS 
The two above components were dissolved in 800 ml water with warming. 
SoLI I 
CuS04 17.3g in 100 ml water. 
SoLI was added to SoLII and the volume was completed to 1 litre. 
Amino acid stock solutions 
Stock solutions of individual amino acids were prepared at concentrations of 2 
mg/ml then autoclaved. They were used at a final concentration 20 J.Lg/ml. 
Vitamin1 stock solution 
A stock solution of 1 mg/ml thiamine was prepared. It was used at a final con-
centration 10 J.Lg/ml. 
IPTG 
A stock solution of 100 mM was prepared and used at a final concentration 0.05 
mM. 
Antibiotic stock solutions 
Stock solutions of ampicillin 25 mg/ml in 70% ethanol, tetracycline and 5 mg/ml in 
absolute ethanol, kanamycin 25 mg/ml in sterile H20, chloramphenicol 20 mg/ml 
in absolute ethanol and rifampicin 10 mg/ml in DMF were prepared. They were 
used at the final concentrations 50 J.Lg/ml, 10 Jl-g/ml, 50 f.J-g/ml, 10 Jl-g/ml and 200 
J.Lg/ml respectively. 
Gel loading dye solution 
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1 ml 10% SDS, 2 ml of 250 mM EDTA pH 8.0, 0.2 ml 1M Tris-HCl pH 8.0, 5 m1 
100% glycerol and 10 mg of Bromophenol blue and the volume was completed to 
10 ml by sterile water. 
Loading buffer for gel retardation assay 
To 1 mg/ml BSA, 50% glycerol and 0.01% xylene cyanol were added then the 
volume was made up to 1 ml by D.water. 
Sequencing stop buffer(formamide-dye mix) 
To 98% deionized formamide (w/w), 10 mM EDTA pH 8.0, 0.2% bromophenol 
blue (wjv) and 0.2% xylene cyanol (w/v) were added and the volume was com-
pleted to 1 ml. 
2.4 Sterilization. 
All the media and glassware used in this work were autoclaved at 15 p.s.i., 
123°C for 15 minutes. 
2.5 Extraction with Phenol. 
The remov al of proteins from nucleic acids solutions was carried out as 
follows:- An equal volume of phenol was mixed with the DNA sample and then 
vortexed for few seconds. After standing for a few minutes and vortexing again it 
was centrifuged for 3 minutes. The aqueous layer was removed into a new tube. 
An equal volume of chloroform was added (chloroform is always 24:1 mixure of 
chloroform and isoamylacohol), vortexed then centrifuged. The Upper layer was 
transferred into a fresh tube. 
2.6 Precipitation of DNA. 
In order to concentrate DNA in a sample or to change buffers, ethanol pre-
cipitation was carried out as follows:- DNA volume was estimated, 0.1 volume of 
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3M sodium acetate pH 4.8 and 2 volumes of ethanol were added, mixed and kept 
at -80°C for at least 15 minutes. DNA was recovered by centrifugation at 12000 
rpm for 10 minutes. The pellet was washed with 70% ethanol. Finally the pellet 
was dried under vacuum and resuspended in TE buffer. 
2. 7 Preparation of the Dialysis tubing. 
Dialysis tubing was boiled for 10 minutes in a solution containing 2% N a2C03 
(w/v) and 1 mM EDTA (final concentration) pH 8.0. Then the tubing was rinsed 
five times in cold water, followed by another 10 minutes boiling in water. Finally, 
the tubing was rinsed several times in water and then stored at 4°C. 
2.8 Spectrophotometric quantation of DNA. 
The concentration of nucleic acid solutions was measured spectrophotome-
terically at 260 nm using an Ultrospec 4050. The concentration was calculated 
using the following formula:-
Optical density at 260 nm of 1 = 50 J.Lg/ml. 
2.9 Digestion of DNA with restriction enzymes. 
All the digestions with restriction enzymes in this work were carried out 
overnight unless it is stated elsewhere. The digestion reactions were set up as 
follows:- 0.2-1 J.Lg of DNA sample was mixed with distilled water to give a volume 
of 18 J.LL 2 J.Ll of the appropiate lOx digestion buffer was added, followed by 1 J.Ll of 
a restriction enzyme (5 unit/ J.Ll). The contents were mixed and then centrifuged 
for a few seconds to recover the components to the bottom of the tube followed by 
incubation at the appropriate temperature. The digestion reaction was stopped 
by the addition 3 J.Ll of a gel loading dye then loaded into the gel slot. Sometimes, 
it is necessary to purify the restricted DNA by extraction with phenol/chloroform 
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and concentrate the DNA by ethanol. Throughout this work, digestion with two 
restriction enzymes are required for certain purposes, in this case the digestion of 
DNA sample was performed by adding the two restriction enzymes simultaneously. 
2.10 Preparation of restriction enzyme buffers. 
Three different salt concentrations are used for the digestion of DNA molecules 
with restriction enzymes. These are low, medium and high buffers and are pre-
pared in 10 times concentrations. 
lOx Low salt buffer solution:-
100 mM Tris-HCl pH 7.5, 100 mM MgCl2 and 10 mM DTT. 
lOx Medium salt buffer solution:-
500 mM NaCl, 100 mM Tris-HCl pH 7.5, 100 mM MgCh and 10 mM DTT. 
lOx High salt buffer solution:-
1000 mM NaCl, 500 mM Tris-HCl pH 7.5, 100 mM MgCl2. 
2.11 Agarose gel electrophoresis. 
Various percentages of agarose gel could be prepared depending on the size 
of DNA fragment of interest. Normally, 0. 7% agarose is used but concentrations 
up to 1.5% can be used for the separation of small DNA fragments. The required 
amount of agarose was added to 200 ml solution of 1x Alec's buffer and boiled 
for 10 minutes. The gel solution was cooled down to approximately 45°0 and 
poured onto a glass plate (180x150 mm) surrounded by a gel former, the comb 
was inserted and the gel allowed to set. 
The comb and sourrounding former were removed and the gel soaked in a gel 
tank containing 2 litres of 1x Alec's buffer. The DNA samples containing gel dye 
were loaded into the wells. Then the gel apparatus was connected to the power 
and then electrophoresed for 3 hours at 80 volts. After electrophoresis, the gel 
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was taken out from the tank and visualized on a UV transilluminator. The gels 
were photographed using Polaroid film. 
2.12 Acrylam.ide gels for the retardation assays. 
Polyacrylamide gels were used in this work to establish the binding of upsilon 
protein to particular ilvYC DNA sequences. 8% polyacrylamide gels were utilized 
for this because they show effective separation of DNA fragment in the size range 
of 60-300 bp used in this assay. The gel was prepared as follows:- To 26.6 ml 
of 30% acrylamide (29% acrylamide, 1% bisacrylamide), 61.3 ml water, 2.1 ml 
3% ammonium persulphate and 10 ml lOx TBE buffer were mixed, Next, the 
gel solution was degassed, 30 J.Ll TEMED was added, mixed and the gel solution 
poured. After polymerization the comb was removed and the gel mounted onto 
the apparatus. The two reservoirs of the apparatus were filled with 1x TBE buffer. 
The sample reactions were loaded and the apparatus connected to the power pack. 
The gel was electrophorsed at 1 Ov /em for 3-4 hours. After electrophoresis the 
gel was removed and directly dried after being wrapped with cellophane viscous 
membrane. The dried gel was then exposed to X-ray film. 
2.13 Preparation of SDS-PAGE Gel. 
This gel involves preparation of two gels, the acrylamide gel and the stacking 
gel. Various percentages of this gel could be prepared and it depended upon the 
molecular weight of the monomer protein. In this work 10% SDS gels were used 
and prepared as follows:-
Acrylamide gel 
22.5 ml1 M Tris-HCl pH 8.8 
20 ml 30% acrylamide solution 
15.4 ml sterile water 
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The solution was degassed then 
0.6 ml 10% SDS 
150mg Ammonium persulphate 
20 pl TEMED 
Then, the solution was poured between two clean glass plates (175x190mm) with 
spacers until the level of fluid reached four-fifths up the glass plate. Followed by 
addition of 1 ml isopropanol to obtain an even surface. 
Stacking gel 
2.5 ml Tris-HCl pH 6.8 
2.0 ml 30% acrylamide 
14.8 ml sterile water 
Degassed then add 
0.2 ml 10% SDS 
100mg Ammonium persulphate 
20 pl TEMED 
The stacking gel solution was poured over the polymerized acrylamide gel then 
the comb was inserted and the gel left for polymerization. Then, the comb and 
the bottom spacer were removed and the gel mounted to the appartus. The two 
ell 
reserviors were filled with 1x PAGE buffer. 
The protein samples were mixed with an equal volume of 2x sample buffer and 
then heated in a boiling water bath for 3-5 minutes and finally loaded alongside 
appropiate protein markers. The gel was electrophorsed at 40 volts, overnight. 
2.14 Silver staining method for SDS-PAGE gels. 
This method of staining has the ability to detect protein bands at very low 
concentrations. It is much more sensitive than the Coomassie staining method. 
After the protein gel was removed from the glass plate it was soaked in 50% 
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methanol solution for at least 2 hours. Next, the gel was washed with water and 
stained with solution C for 15 minutes with constant shaking. This was followed 
by washing the gel in water for 5 minutes then soaking in solution D (developer). 
It was left in developer until the protein bands appeared then washed with water 
and placed in 50% methanol solution to stop the developer reaction. Alternatively, 
developer action could be slowed down by the addition of 5-10% methanol to the 
developer solution. The gel was then washed with water and dried under vacuum. 
Sometimes, the development of the protein bands is too fast and the gel 
becomes a uniform dark brown in colour. In this case destaining of the gel was 
carried out by soaking the gel in destain solution containing equal volumes of 
solutions E and F diluted with 4 volumes of water. 
Solution A 
0.8g silver nitrate in 4 ml D.water. 
Solution B 
1 ml of 0.36% NaOH and 0.7 ml of 0.88% ammonia. 
Solution C 
Solution A mixed with solution B with continous stirring. A few drops of 0.88% 
ammonia solution were added to clear the brown colouration, then the volume 
was completed to 100 ml. 
Solution D (Developer) 
2.5 ml of 1% citric acid and 0.25 ml 38% formaldehyde were mixed and the volume 
completed to 500 ml. 
Solution E 
1.5 M sodium thiosulphate. 
Solution F 
0.15 M CuS04, 0.6 M NaCl and 0.9 M NH40H. 
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2.15 Protein determination. 
Two methods were used to determine protein concentration. These are the 
Biuret and Bio-Rad microassay procedures. 
Biuret assay :- 750 J.Ll of 1M NaOH was mixed with 50 J.Ll Benedict's reagent 
and 50 J.Ll of protein sample and the volume made to 1 ml. The reaction was left 
at room temperature for 15 minutes then the protein concentration was estimated 
using an Ultraspec 4050 at 330 nm. A Sample reaction without protein was used 
as a blank. A calibration curve of BSA was used. 
The Bio-Rad microassay method was used to estimate the concentration of 
proteins especially in fractions from column chromatography. To 300 J.Ll of each 
sample was added 600 J.Ll diluted dye reagent (1 volume of dye mixed with 4 
volumes of water), followed by mixing. The O.D. were measured at 595 nm using 
an Ultraspec 4050. A calibration curve of BSA was made. 
2.16 Purification of DNA restriction fragments from low melting point 
agarose gels. 
The preparation and running of a 0.7% gel was as described in (section 2.11) 
except that low melting point Agarose was used. The DNA fragment of interest 
was excised from the gel and tr~ferred to an eppenderoff tube after removing as 
much as possible of the gel from the fragment. This was then placed in a water 
bath at 68°C until melted. After that, 2 volumes of TE buffer was added, and left 
for 5 minutes at 37°C. This was followed by phenol extraction at least two times, 
then chloroform extraction and the DNA was finally precipitated by ethanol. The 
pellet was resuspended in an appropriate volume of TE buffer. 
2.17 Dephosphorylation of DNA fragments. 
I 
Sometimes, it is necessary to remove 5 terminal phosphate groups from DNA 
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fragments to avoid self ligation of the DNA molecules. The process was carried 
out as follows:- To 1 J..Lg of restricted DNA fragment 1/10 volume of lOx CIP 
buffer and 1 unit of alkaline phosphatase were added and the volume made to 18 
JLL The sample was incubated for 30 minutes at 37°C. Then, 4.8 J..Ll of 100 mM 
NTA (nitrilotriacetic acid) was added followed by heating for 15 minutes at 70°C 
in a water bath. The sample was then phenol/chloroform extracted and finally 
ethanol preciptated. The pellet was resuspended in an appropiate volume of TE 
buffer. 
2.18 Ligation of DNA fragments. 
Ligation of restricted DNA molecules was achieved as follows:- Insert DNA 
and up to 0.5 J..Lg of vector DNA, 3 J..Ll of lOx ligase buffer and 1 J..Ll of T4 DNA 
ligase were mixed in a total volume of 30 J.Ll. The ligation reaction was carried 
out at l5°C, overnight. 
A molar ratio of the insert to vector DNA of 2:1 was used to reduce self 
ligation of the vector. Sometimes, the overnight ligation reaction was followed by 
phenol/ chloroform extraction to increase the efficiency of transformation. 
2.19 Transformation and preparation of competent cells. 
Transformation of bacterial cells by the calcium chloride technique was carried 
out as described by Mandel and Higa (1970). Competent cells were prepared as 
follows:- 50 m1 L-broth was inocculated with 1 ml of an overnight culture and 
then incubated with shaking at 37°C for 2 hours to reach log phase. Cells were 
harvested by centrifugation for 10 minutes at 6000 rpm at 4°C. The pellet was 
resuspended in 40 ml of cold transformation buffer and then placed on ice for 1 
hour. They were then centrifuged as above and finally resuspended in 1 ml of the 
same buffer. The cells are now competent for transformation. 
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To carry out transformation, 100 ,ul of competent cells were mixed with at 
least 0.01 ,ug of DNA and kept on ice for 20 minutes. Following a heat shock for 2 
minutes at 42°C, 1 ml of L-broth was added and the cells left for 1 hour at 37°C 
to express antibiotic resistance. Aliquots were then plated on selective media. 
2.20 Preparation of Sephadex G-50 and G-25 columns for the separation 
of DNA from unincorporated nucleotides. 
30g of Sephadex G-50 or G-25 (medium) was suspended in 250 ml TE buffer 
pH 8.0. The suspension was then autoclaved to swell the gel. The solution was 
then left to cool down to room temperature. The supernatant was removed and 
replaced with an equal volume of TE fresh buffer pH 8.0. The swollen gel was 
stored at 4°C. 
A disposable 5 ml glass pipette was plugged with a sterile siliconized glass 
wool. The Sephadex suspension was applied to the column after preloading 5 
ml of TEN buffer to the plugged column. The outlet was then opened and the 
application of Sephadex was continued until the bed level filled four-fifths of the 
column. The column was then washed with 10 ml TENS buffer. Next, the sample 
was applied to the column, more TENS buffer was added and fractions of 0.5 ml 
were collected. 
The detection of the radioactivty in the fractions was by liquid scintillation 
counting. Two peaks were obtained from chromatograhy through Sephadex. The 
leading peak consists of the labelled DNA while the trailing peak consists of 
unincorporated nucleotides. Finally, the peak fractions containing the DNA were 
mixed and stored at -20°C. 
2.21 Nick translation of DNA restriction fragments. 
Amershams nick translation kit was used to label in vitro DNA restriction 
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fragments. Solution I is a nucleotide buffer which contains a mixure of dATP, 
dGTP and dTTP in a concentrated nick translation buffer. Whereas, solution II 
is a buffer solution containing DNA polymerase I and DNase (deoxyribonuclease). 
The reaction was carried out as follows:- To 3 J-tg purified DNA, 12 J-£1 solution I 
3'2. (nucleotide buffer), 5 J-£1 of o:-P -dCTP (specific activity 410 Ci/mmol) and 5 J-£1 
solution II (enzyme mixure) were added and the volume completed to 30 J-£1. The 
reaction components were mixed and centrifuged for few seconds. The sample 
was incubated at l5°C in a water bath for 90 minutes. The nick translation 
reaction was applied to a Sephadex G-50 column to separate the DNA fragment 
from unincorporated nucleotides as described above. 
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2.22 P· Labelling of restriction fragments by "filling" in. 
I 
Restriction fragments were labeled by filling the recessed 3 end of double 
stranded DNA as follows:- To 2 J-tg DNA fragment, 3 J-£1 of lOx nick translation 
buffer, 2 J-£1 of each 2 mM unlabeled dGTP, dCTP and dTTP solutions, 2 J-£1 of 
o:~P· dATP (specific activity 410 Ci/mmol) and 2 J-£1 of DNA polymerase I Klenow 
enzyme (1 unit/ J-£1), the final volume was completed to 25 J-£1. The components 
were mixed, centrifuged for a few seconds and incubated at room temperature for 
30 minutes. The DNA was separated from unincorporated deoxynucleotides as 
described above. 
2.23 Labelling of restriction fragments by T4 polynucleotide kinase. 
I 
Fragments with protruding 5 termini were labeled as follows:- 3 J-tg of DNA 
was dephosphorylated by treatment with Alkaline phosphatase then to this 5 J-£1 
lOx kinase buffer, 5 J-£1 of ]-p' ATP (specific activity 5000 Ci/mmol) and 20 units 
of T4 polynucleotide kinase were added and the volume was completed to 50 
J-£1. The contents were mixed well, centrifuged for a few seconds to recover the 
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components to the bottom of the tube and then incubated for 60 minutes at 37°e. 
The sample was then applied to a Sephadex G-50 column to separate the DNA 
from the unincorporated nucleotides as described above. 
Fragments with blunt-ends were labeled by the following method. After de-
phosphorylation of 2 J.Lg of restriction fragment, 4 J.Ll of a solution containing 0.2 M 
Tris-Hel pH 9.5, 10 mM spermidine and 1 mM EDTA was added and the volume 
completed to 40 J.Ll. Next, the samples reactions were heated at 70°e a water bath 
for 5 minutes and then chilled on ice. Next, 5 J.LllOx blunt end kinase buffer, 5 J.Ll 
of "Y~p<.-ATP (specific activity 5000 eijmmol) and 20 units of T4 polynucleotide 
kinase were added to the sample, mixed, centrifuged for a few seconds and incu-
bated for 30 minutes at 37°0. After that, the reaction samples were applied to a 
Sephadex G-25 column to separate DNA from the uninc,orated nucleotides. 
2.24 Northern Blotting. 
The gel was soaked in 20x SSe for 1 hour. Then over a glass plate a large 
piece of 3MM paper, soaked in lOx sse, was placed such that the ends dipped 
into a tray containing lOx SSe. The paper was then smoothed over to remove any 
air bubbles. The gel was placed on it and was covered with a wet nitrocellulose 
filter already soaked in lOx SSe without allowing any air bubbles trapped. Next, 
3 layers of wet 3MM paper soaked in lOx SSC and 3 layers of disposable nappies 
were placed on then a glass plate and a heavy weight. The blott was then left 
overnight. The nitrocellulose filter was then transferred to 3MM paper and allowed 
to dry at room temperature, then in a vacuum oven for 3-4 hours at 80°e. 
2.25 Preparation of plasmid DNA. 
"Mini-Prep" method 
The method used was as described by Birnboim and Doly (1979). A 5 ml 
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overnight culture of a plasmid bearing strain was centrifuged and resuspended 
in 180 j.tl of solution I then 8 J.£1 of stock lysozyme solution (50 mg/ml). 400 J.£1 
of solution II was added and vortexed gently. The mixture was placed on ice 
for 5 minutes after which 300 j.tl of 3M sodium acetate was added followed by 
gentle vortexing. After a further 10 minutes on ice the cells were centrifuged 
for 5 minutes. 800 j.tl of supernatant was removed and mixed with 500 JLl of 
isopropanol. The mixure was kept at -20°C for 15 minutes, then centrifuged for 5 
minutes. The pellet was washed with cold 70% ethanol and then resuspended in 
200 j.tl TE buffer. After repeated phenol and chloroform extraction the DNA was 
once more ethonal precipitated and finally resuspended in 100 J.£1 TE buffer. 
Solutions 
Lysozyme stock solution 
50 mg lysozyme in 1 ml water. This was used at a final concentration of 2 mgjml. 
Solution I 
2% glucose, 80 mM EDTA pH 8.0 and 50 mM Tris-HCl pH 8.0. 
Solution II 
Freshly made 0.2 M NaOH and 1 % SDS. 
50 ml-Scale preparation of plasmid DNA. 
This essentially a modified scaled up of the method of Birnboim and Doly 
(1979). 50 ml L-broth of was inoculated with a single colony in the presence 
of a suitable antibiotic and incubated overnight with shaking at 37°C. The cells 
were then centrifuged at 8000 rpm for 10 minutes at 4°C. The pellet was resus-
pended in 2 ml of solution I with lysozyme (5 mg/ml), left for 10 minutes at 
room temperature then 4 ml of solution II was added, mixed by inversion and left 
on ice for 10 minutes. This was followed by adding 3 ml of cold 5M potassium 
acetate pH 4.8 and then left on ice for another 10 minutes. The lysed bacteria 
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were then centrifuged as above. The supernatant was removed and extracted with 
phenol/chloroform (equal volume). The aqueous layer was transferred to a clean 
corex tube and the DNA was precipitated with 2 volumes of ethanol. After cen-
trifugation the pellet was washed with 70% ethanol, dried then resuspended in 
500 111 TE buffer. 
Large scale preparation of plasmid DNA. 
In order to obtain more purified plasmid DNA and in high yield, Caesium 
chloride-Ethidium bromide purification was used. A 500 ml culture of bacteria 
was grown at 37°C with vigorous shaking after inoculation with a 5 ml overnight 
culture. After the culture reached stationary phase the cells were harvested by 
centrifugation in an MSE 18 at 7000 rpm for 10 minutes. The supernatant was 
removed and the pellet resuspended in 10 ml solution I. The suspension was trans-
ferred to a clean 250 ml beaker, followed by addition of 50 mg lysozyme and was 
left for 10 minutes at room temperature. Then 20 ml of solution II was added and 
left on ice for 10 minutes then finally 15 ml of 3M sodium acetate was added and 
left for another 10 minutes. The lysed cells were clarified by centrifugation in an 
MSE 18 for 45 minutes at 15000 rpm at 5°C. The supernatant was retained and 30 
ml of isopropanol was added, mixed and left for 30 minutes at room temperature. 
The precipitated nucleic acids were recovered by centrifugation for 30 minutes at 
12000 rpm at room temperature. The pellet was retained and resuspended in 15 
ml TE buffer. Following that purification through a Caesium chloride-Ethidium 
bromide gradient was carried out as follows. One gram of Caesium chloride for 
each 1 m1 of resuspended pellet was added and mixed until the Caesium chloride 
dissolved completely. Then 0.3 ml of 10 mg/ml solution of ethidum bromide was 
added and the solution transferred to a measuring cylinder to complete the volume 
to 27 m1 with TE buffer containing the same concentration of Caesium chloride 
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used above. The 27 m1 solution was transferred into a Quickseal centrifuge tube 
and centrifuged overnight at 44000 rpm at 15°C using a Sorvall ultracentrifuge 
and a VTi 50 rotor. 
Two bands appeared in the gradient, the lower one comprises the plasmid 
DNA. This band was removed using a syringe and the solution obtained was ex-
tracted with an equal volume of isopropanol saturated with Caesium chloride to 
remove the eithidum bromide. This process was repeated until no ethidium bro-
mide remained in the solution. Finally, the extracted DNA solution was dialysed 
against TE buffer for 4-5 changes at 4°C, overnight. 
Sometimes it is necessary to recentrifuge the DNA through a CsCl-EtBr gra-
dient to obtain highly purified plasmid DNA and this was performed as follows:-
After removing the plasmid DNA from the gradient it was transferred to another 
a Quickseal tube and the volume completed to 27 m1 with TE buffer plus CsCl as 
before, followed by centrifugation under the same conditions described above. 
2.26 Transformation of recombinant Ml3mp18 and M13mp19 vectors. 
Competent cells from JM101 were prepared and transformed following the 
general method for transformation (see section 2.19) except the buffer is 50 mM 
CaCh only. 
Plating the transformed cells was carried out as follows:- to each tube con-
taining 3 m1 of top agar at 42°C, the transformed cells (after heat shock), 200 JLl 
of fresh log-phase of JM101, 10 JLl of 100 mM IPTG and 20 JLl of 10% X-gal were 
added. These components were mixed and the entire contents plated onto L-agar 
plates. After the top agar had set the plates were incubated at 37°C. 
2.27 Preparation of single-stranded M13mp DNA. 
50 m1 of 2x YT media was inoculated with 100 111 of an overnight JM101 
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culture. Then 2 ml of this was transferred into 12 sterilized universal bottles. 
11 white and 1 blue (which was used as a standard) plaques were picked and 
resuspended into the 12x2 ml bottles. These were incubated at 37°C. 
1.5 ml was transferred from each bottle to an eppenderoff tube and the cells 
pelleted. The supernatant was taken from each tube and recentrifuged to remove 
any remaining cells. 1 ml from each sample was transferred to a new tube and 
200 J.£1 of 20% polyethylene glycol 2.5 M NaCl was added, then left at room 
temperature for 20 minutes followed by centrifugation for 10 minutes at 13000 
rpm. The supernatant was discarded and the tubes recentrifuged for 10 seconds, 
the remaining polyethylene glycol was removed by a micropasteur pipette. The 
pellets were resuspended in 100 J.tl TE buffer, then phenol extracted followed by 
chloroform extraction. The DNA was precipitated by ethanol. Finally, the DNA 
pellet was resuspended in 20 J.£1 TE buffer. 
To ensure that single-stranded DNA prepared from recombinant plaques 
(white) contained inserts before using them as template DNA in the sequenc-
ing reactions the following test was done. A 2 J.£1 of the DNA samples from each 
set was loaded alongside M13 single stranded DNA purified from a blue plaque, 
which acts as a size control, to a 0. 7% agarose gel, electrophm\ed and then ex-
amined under UV light. The migration of the DNA fragment from the samples 
prepared should be slower than the DNA fragment that acts as a control. This 
difference in migration depends on insert size. 
2.28 DNA Sequencing. 
For each sequencing reaction there are four incubations. Each incubation 
'35" 
contains all the deoxynucleoside triphosphates, a-S --dATP and one of the four 
dideoxynucleoside triphosphates. The sequencing reactions was carried out as 
follows:- In a 1.5 m1 eppenderoff tube the following components were mixed, 5 J.£1 
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(1 J..Lg) of the DNA template (M13 mp18 or M13 mp19 single-stranded DNA with 
insert), 2 J.Ll (4ng) universal M13 primer (15 bases), 1 J..Ll10x polymerase reaction 
buffer and 4.5 J.Ll sterile water. The total volume is 12.5 J..LL These components were 
centrifuged for a few seconds to collect the components in the bottom of the tube. 
Then, the sample reaction was heated at 85-95°C in a water bath for 5 minutes. 
The sample reaction was then slowly cooled down to room temperature to allow 
annealing of the primer to the DNA template. 2 J.Ll of A° C0, C0 and T0 mixes 
were added to four fresh tubes. Then, to the annealed template-primer mixture, 
'35 
1 J..Ll of a:-8--.dATP (specific activity 410 Ci/mmol), 1 J..Ll of 0.1 M DTT and 1 J..Ll 
of Klenow enzyme (1 unit/ J..Ll) were added and 4 J.Ll aliquots from this mixure were 
dispensed to the four eppendorfftubes (A0, C0 , C0 and T0). The contents of each 
tube were mixed and centrifuged for a few seconds. These incubation mixtures 
were left for 15 minutes at 30°C. Then 1 J..Ll of a chase solution was added to each 
incubation. This chase solution serves to extend the polynucleotide chains which 
have prematurely terminated due to low dATP concentration. After a further 
15 minutes incubation at 30°C, 5 J.Ll of formamide-dye mix was added to each 
incubation. 
2.29 Preparation of DNA sequencing gels and electrophoresis of sam-
pies. 
An 8% Polyacrylamide sequencing gel was prepared as follows:-
Two 20x42 em glass plates were used for preparing the sequencing gel. These 
plates were washed first with teepol and water, wiped dry then washed with 
ethanol. Further, one surface of one plate was siliconized with "Repelcote". The 
two plates with 0.4 mm spacers were taped around the edges with gel sealing tape. 
Then, 42g Ultrapure urea, 20 ml40% acrylamide (19:1 acrylamide-bisacrylamide), 
20 ml10x TBE buffer and 35 m1 water. The above components were mixed and 
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urea was dissolved to completion. Fines were removed by filteration. Following de-
gasing, to remove air from the gel solution, 0.8 ml of 10% ammonium persulphate 
and 20 ,ul of TEMED were added. 
The gel solution was poured between the glass plates using a 50 ml syringe. 
The gel plates were held at an angle of 45° so that the gel solution flows evenly 
into the plates. After addition of the well-forming comb, the gel was allowed to 
set. 
The tape around the bottom and front edges was removed from the gel, then 
it was fixed to the apparatus along with an aluminum plate which ensures an even 
distribution of temperature. The upper and lower reservoirs were filled with 1x 
TBE buffer and the gel was prelectrophoresed for 30 minutes before loading the 
sequencing reaction samples. 
The gel wells were rinsed with the running buffer and the DNA samples were 
heated at 95-100°C for 3-5 minutes then loaded immediately into the gel wells in 
the order A, G, C and T. The gel was electrophorsed at 1500v for about 3 hours 
until the bromophenol blue reached the bottom. Further samples were loaded 
into empty tracks and the gel electrophoresed for an additional 2 hours. After 
electrophoresis the gel was transferred to 3MM paper and dried for at least 3 
hours at 80°C on a vacuum gel drier. 
After the sequencing gel was dried it was exposed to preflashed X-ray film. 
Autoradiography was carried out overnight at room temperature. X-ray films 
were developed in Phenisol developer (Kodak) and fixed in Kodafix (Kodak). 
2.30 Deoxynucleoside triphosphate ( dNTP) and dideoxynucleoside triphos-
phate (ddNTP) mixes. 
The dNTPs are provided in stock solutions of 10 mM. Working solutions 
of 0.5 mM were prepared from these stock solutions then A, G, C and T mixes 
46 
MATERIALS AND METHODS 
prepared from these working solutions as follows:-
A mix 
20 J.LllOx polymerase reaction buffer, 20 J.Ll from each working solution (0.5 mM) 
of dGTP, dTTP and dCTP. 
G mix 
20 J.LllOx polymerase reaction buffer, 1 J.Ll of 0.5 mM dGTP and 20 J.Ll from each 
working solution (0.5 mM) of dTTP and dCTP. 
C mix 
20 J.Ll lOx polymerase reaction buffer, 1 J.Ll 0.5 mM dCTP and 20 J.Ll from each 
working solution (0.5 mM) of dGTP and dTTP. 
T mix 
20 J.Ll lOx polymerase reaction buffer, 1 J.Ll 0.5 mM dTTP and 20 J.Ll from each 
working solution (0.5 mM) of dGTP and dCTP. 
The above mixes were designed for the use with a:S dATP. 
The dideoxynucleoside triphosphate are provided in stock solutions of 10 mM. 
Working solutions of ddNTPs of various concentrations were prepared and from 
these solutions the ddNTP mixes were prepared as follows:-
ddATP mix 
1 J.Ll 0.125 mM ddATP was diluted to 80 J.Ll by sterile water. 
ddGTP mix 
1 J.Ll 0.5 mM ddGTP was diluted to 20 J.Ll by sterile water. 
ddCTP mix 
1 J.Ll 0.5 mM ddCTP was completed to 20 J.Ll by sterile water. 
ddTTP mix 
1 J.Ll 1 mM ddTTP was diluted to 10 J.Ll by sterile water. 
New mixes were prepared by mixing equal volumes of dNTPS and their corre-
sponding ddNTPs mixes. These mixes were given the following symbols:- A 0 , G0 , 
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C0 and T 0• Additionally, chase solution was prepared by diluting 10 mM dATP 
stock solution to 0.5 mM with sterile water. 
2.31 Preparation of S-30 extracts. 
The preparation of S-30 extracts was initially that of Wild et al., (1977) and 
was as follows :- llitre of S-30 media was inoculated with a 5 ml culture of CU827 
and grown at 30°C, overnight with vigorous shaking. The cells were harvested at 
4°C. The weight of the cells was determined and then resuspended in buffer III (10 
ml/ g cells), centrifuged and resuspended in buffer III ( 4 ml/ g cells), centrifuged 
and resuspended in buffer III (1.3 ml/g cells). All centrifugation was at 4°C. 
The cells were lysed in a precooled cell under 1500 p.s.i. and the lysed cells 
were collected on ice. The lysed cells were passed through a fine needle to shear the 
DNA and the passage through the pressure cell repeated. After the addition of 10 
J.Ll of 0.1 M DTT for each ml of lysate the suspension was clarified by centrifugation 
at 15000 rpm in an MSE18 centrifuge using a 8x50 rotor for 30 minutes at 4°C. 
The supernatant was retained and centrifuged again under the same conditions. 
To the supernatant 0.16 ml of preincubation mixture per gm of the original 
pellet was added and incubated in a light protected vessel at 37°C for 80 minutes. 
This allows translation of endogenous mRNA and frees ribsomes. The lysate was 
then dialysed for 3 changes in buffer III at 4°C then distributed into aliquots in a 
screw cap vials, frozen in liquid nitrogen and stored at -80°C. 
2.32 Solutions and media recipes for in vitro ilvC expression. 
S-30 media 
5.6g KH2P04 (anhydrous) 
28.3g K2HP04 (anhydrous) 
lOg Bacto-Yeast extract 
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10-15mg thiamine 
These components were mixed and dissolved in 1 litre water, autoclaved then 40 
ml of 25% glucose was added. 
Buffer III 
Tris-acetate pH 8.2 10 mM 
Mg-acetate 14 mM 
K-acetate 60 mM 
DTT 1 mM 
Preincubation mixture 
Tris-acetate pH 8.2 0. 75 mM 
Mg-acetate 21 mM 
DTT 7.5 mM 
A solution of 20 amino acids 75 J.LM each 
ATP 6 mM 
Phosphoenol pyruvate 67.5 mM 
Pyruvate kinase 20 J.Lg/ml 
Solution 2 {Supplement sloution from the kit) 
This contains sufficient nucleotides for transcription, tRN A for translation, an 
energy-generating system and inorgnic salts. 
Solution 3 
It contains an equimolar mixture of amino acids minus methionine. 
Solution 5 
It is a dilution buffer. 
2.33 Bacterial strains and plasmids. 
Bacterial strains and plasmids used in this work are listed in Tables 2.1 and 2.2 
respectively. Constructed plasmids used in this work are listed in Table 2.3. 
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Table 2.1 Bacterial Strains 
Strain Description source of reference 
A it is C600 A- contains pGP1-2 and This work 
pDUB2411. 
B it is C600 A- contains pGP1-2 and This work 
pDUB2412. 
c It is JM83 contains the ilv yc gene. This work 
CU152 Jr, ara fl. (lacpro} thi. Cold Spring 
Harbor 
Laboratory. 
CU176 F"", ara ll.{lacpro} thi, Cold Spring 
SmR. Harbor 
Laboratory. 
CU827 fl. ilvDAC115 ara thi, M. Watson 
ll.{proAB-lac}. et. al. (1979). 
CU962 ilvY2149 rbs-215 ara thi, Biel and 
ll.{pro-lac}. Umbarger 
(1980). 
JM83 ara, ll.(lac-proAB} rpsL, Vieira and Messing 
(=strA}, tjJ80, ll.M15. (1982). 
JM101 supE, thi, ll.{lac proA,B}, Yanish-Perron 
F', traD36, proA,B, lacflZ M15. et. al. (1985). 
MC4100 F' araD139 ll.{argF-lac}U169 University of 
rpsL150 relAl deoCl ptsF25 Texas. 
rbsR ftbB5301. 
Table 2.2 Plasmids 
Plasmids Description Source of 
Reference 
pBR328 Wild-type plasmid bla+, tet+, Soberon 
em+. et. al. 
(1980). 
pDUB2007 RP4::ilvC::lacZ, Km+. M. Watson 
(1979). 
pDUB2012 RP4::ilvC::lacZ and ilvY::Tn7. M. Watson 
(1979). 
pDUB2013 RP4::ilvC::lacZ, ilvY+, Tn7. M. Watson 
(1979). 
pGEM-Blue it is the first SP6/T7 pGEM vector, "Promega" 
bla+ Biotech." 
pGP1-2 it contains two promoters, Tabor and 
Pzac and PL, Km+. Richardson 
(1985). 
pGMM201 pBR322n1 0{3. 612kb:>.80ilv McCorkle 
ilvAYC-0.27-4.35kb( + )}. et. al. 
(1978). 
pMC1871 It is a fusion vector, Tet+, "Promega" 
contains a promoterless lacZ fragment. Biotech." 
pUC19 wild-type plasmid bla+. Yanisch-
Perron 
et. al. 
(1985 ). 
Table 2.3 Constructed plasmids used in this work. 
I 
Plasmid I Description 
I 
Source of 
reference 
----------1---------------------------------- ---------------
1 
pDUB2400 I 
I 
I 
pDUB2401 I 
I 
I 
pDUB2402 I· 
I 
I 
I 
I 
I 
I 
pDUB2403 I 
pDUB2404 
pDUB2405 
pDUB2406 
pDUB2407 
pDUB2408 
pDUB2409 
EcoRl ilvYcfragment in pUC19. 
. + EcoRI 1lvY fragment in pUC19. 
Small EcoRI-Bglii fragment of 
wild-type ilvY gene and large 
Bglii-EcoRI fragment of consti-
tutive ilvY gene into EcoRI of 
pUC19. 
Small EcoRI-Bglii fragment of 
constitutive ilvY gene and large 
Bglii_EcoRI fragment of wild-type 
ilvY gene into EcoRI site of pUC19. 
Bglii-Hindiii fragment from 
pDUB2401 into pDUB2400 after 
removing its Bglii-Hindiii fragment. 
I 
I 
Bglii-Hindiii fragment from I 
pDUB2400 into pDUB2401 after I 
removing its Bglii-HinDIII fragment. I 
BamHI KanRfragment from pDUB2033 
into pDUB2405. 
BamHI KanRfragment from pDUB2033 
into pDUB2404. 
BamHI KanRfragment from pDUB2033 
into pDUB2401. 
BamHI KanRfragment from pDUB2033 
into pDUB2400. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
Plasmid Description 
pDUB2411 EcoRI ilvYcfragment in pGEM-Blue. 
(Orientation 1) 
pDUB2412 Opposite orientation to pDUB2411. 
pDUB2414 EcoRI i 1 vY+ fragment in pBR328. 
(Orientation 1 ) 
pDUB2415 Opposite orientation to pDUB2414. 
pDUB2416 Psti-Bglll ilvC fragment from 
pGMM201 in pUC19. 
pDUB2417 lacZ fragment from pMC1871 in 
pDUB2414. 
pDUB2418 1 acZ fragment from pMC1871 in 
pDUB2415. 
Bacteriophages 
I 
Bacterioph- I Description 
ages I 
Source of 
reference 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
Source of refer-
ence 
----------1---------------------------------- ---------------
1 
M13mp18 I Multiple cloning sites. BRL 
I 
M13mp19 I Multiple cloning sites. BRL 
CHAPTER 3 
Characterization of the ilvYc mutation 
3.1 Introduction. 
RESULTS 
This chapter seeks to characterize the ilvY2143 mutation that makes ilvC 
expression in the strain CU962 constitutive (Biel and Umbarge, 1980). The first 
question addressed was, does ilv Y regulate ilvC expression at the level of tran-
scription. Secondly, the nature of the mutation in the ilvYc mutant gene was 
determined by sequencing both ilvY+ and ilvYc and comparing the nucleotide 
sequences. Lastly, experiments were carried out to confirm that the observed sin-
gle base change is responsible for making ilvC expression constitutive due to the 
ilvY product (upsilon) no longer needing the substrates a-acetohydroxybutyrate 
or acetolactate for induction of ilvC. 
3.2 Does upsilon act at the transcriptional level?. 
The experiment involves the extraction of RNA from different bacterial strains 
(CU152 wild-type, CU827 tlilvDAYC, CU962 ilvYc) grown under repressing and 
derepressing conditions. The RNA was characterized by Northern blotting then 
the hybridization of these RNA species to a radiolabelled ilvC probe. 
The following sets of cultures in different media were prepared :-
1. 10 ml cultures of CU962, CU827 and CU152 in 2x YT media. 
2. 10 ml cultures of CU962, CU827 and CU152 in M9 minimal media containing 
isoleucine, leucine and valine (repression media). 
3. 10 ml cultures of CU962, CU827 and CU152 in M9 minimal media grown as 
follows. After growth in M9 containing isoleucine, leucine and valine, the cultures 
were centrifuged then resuspended in minimal media without the above amino 
acids, except CU152 in which valine was included. This acts to derepress the 
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expression of all ilv genes. The cultures were grown for at least 3 hours at 37°C 
after derepression. 
The RNA was extracted from the cultures by the following method:- 1 m1 
was transferred from each culture to a 1.5 ml eppendorff tube, centrifuged and 
resuspended in 100 J.Ll lysis buffer (20% sucrose, 20 mM Tris-HCl pH 7.6, 10 
mM EDTA and 50 mM NaCl) plus 10J.Ll of 10 mg/mllysozyme. The cells were 
kept on ice until the suspensions became viscous (at least 10 minutes). The lysis 
was completed by the addition of 100 J.Ll of 2% SDS. Next, 10 J.Ll of 5 mg/ml 
Proteinase K was immediately added and the samples were vortexed. Finally, the 
lysate samples were frozen and thawed twice by using liquid nitrogen and a water 
bath at 45°C then 50 J.Ll of loading dye (40% glycerol, 100 mM EDTA and 0.1% 
bromophenol blue) was added. 
To determine the integrity of RNA in the lysate samples. 6 J.Ll aliquotes from 
each sample were electrophoresed in 1% agarose gels. Two bands were visible in 
the gel which represent the ribosomal RNA. Then the lysate samples were used 
for RNA analysis. 
The RNA species were sepqrated on an agarose-formaldehyde gel which was 
prepared as follows:- 1g agarose in 70 ml water was autoclaved then cooled to 
65°C and the following components were added, 20 ml MOPS running buffer (0.2 
M MOPS, 50 mM sodium acetate, 5 mM EDTA) and 10 ml formaldehyde, mixed 
and poured into a horizontal gel appartus. After the gel had set it was immersed 
in lx TBE buffer. Before loading, the lysates samples were denatured at 65°C in 
a water bath for 15 minutes and the gel wells were rinsed. Electrophoresis was 
carried out in a fume hood. After electrophoresis the gel was viewed with a UV 
transilluminator and photographed (see Fig.3.1). 
The nucleic acids were transferred to a nitrocellulose filter by Northern Blot-
ting (see section 2.24). 
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Fig. ( 3.1 ). 
A. 1% agarose-formaldehyde gel electrophoresis for the separation of RNA species 
extracted from three bacterial strains, CU152, CU827 and CU962 under different 
growth conditions. 
B. No hybridization was detected with any RNA extracted from cells grown with 
M9 media under both repressing and non-repressing conditions (lanes 1, 2, 4, 5, 
7, & 8). No hybridization was detected with RNA from CU152 grown with 2x 
YT (lane 9). Hybridization was detected to RNA from strain CU962 (lane 3) and 
CU827 (lane 6) grown with 2x YT. 
CU962 
I I 
1 2 3 
CU962 
1 3 
CU827 
I I 
4 5 6 
CU827 
4 5 6 
CU152 
I I 
7 8 9 
7 
CU152 
8 9 
RESULTS 
In order to carry out the hybridization, a radiolabelled probe the EcoRl ilvC 
fragment was prepared by a technique known as random priming. 1 J.Lg of the 
EcoRI fragment was denatured by heating it for 10 minutes at 95°e and subse-
quent cooling on ice. The DNA was made radioactive by synthesising the sec-
ond strand on the denatured DNA using sheared salmon sperm DNA as random 
32 ' 
primers and incorporating a-P ·-deTP. Unincorporated nucleotides were removed 
by applying the reaction sample to a Sephadex G-50 column. The probe was la-
belled to a specific activity of 1.4x107 cpm/ J.Lg. 
The baked nitrocellulose filter was floated on the surface of 6x SSe until wet 
from beneath, then it was immersed in the solution for 2 minutes then transferred 
to a plastic bag with 0.2 ml of prehybridization buffer warmed at 68°e for each em 
square of the filter. The filter was incubated for 2-4 hours at 68°e in a water bath. 
Next, the prehybridization solution was exchanged with hybridization buffer with-
out allowing any air bubbles to be trapped, the bag sealed and incubated further 
at 68°e overnight. Then the filter was washed to remove unbound radioactive 
material, in 200 ml buffer containing 2x sse and 0.5% SDS for 30 minutes at 
68°e then in 200 m1 containing 0.1x SSe and 0.5% SDS for 30 minutes at 68°e. 
The filter was then placed on 3MM paper for drying, wrapped in cling film and 
applied to X-ray film for autoradiography. 
After hybridization the filter was washed, dried and exposed to X-ray film. 
Examination of the autoradiograph (see Fig.3.1) shows that hybridization has 
occured. The extent of hybridization is proportional to the amount of mRN A 
loaded. Most hybridization occurs with RNA from strain eU962 (bearing the 
ilvYc mutation). Less occurs to eU827 (~ilvDAYC) and very little to eU152 
(wild-type). 
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3.3 Nucleotide sequencing of the ilvY gene. 
In order to sequence the ilvYc gene, it was first subcloned from plasmids pPl, 
pH3 and pH4 (M. Watson, unpublished results). These carry either Pstl or Hindlll 
genomic fragments of CU962 in pBR322. They were characterized as being able 
to complement ilvA- strains and also to induce an ilvC::lacZ fusion strain in the 
absence of inducers (ilvYc phenotype) (M. Watson, unpublished results). pPl, 
pH3 and pH4 were digested with EcoRI and electrophoresed on a 0. 7% agarose gel. 
The ilvY EcoRI fragment (see Fig.3.2) was identified by comparison with digested 
pGMM201 (see Fig.3.3A), purified and cloned into pUC19. The resulting plasmid 
is pDUB2400. pDUB2401 is the wild-type EcoRI ilvY fragment from pGMM201 
into pUC19. 
Both the ilvY wild-type and mutant genes were sequenced using the Sanger 
chain termination method (1977). The two recombinant plasmids, pDUB2400 and 
pDUB2401, were restricted with EcoRI and then Bglll and the digested molecules 
were loaded onto a 0. 7% low melting point agarose gel, electrophoresed and the 
generated ilvY DNA fragments (small 220 bp and large 1000 bp) from each di-
gestion were purified (see Fig.3.3B). 4 fragments in total. 
Then, each of the small and large fragments were ligated to EcoRI plus BamHI 
restricted M13mp18 and M13mp19. These ligated plasmids were transformed into 
JM101 (see'section 2.26), screened for recombinant plaques followed by prepara-
tion of recombinant single stranded M13mp18 and M13mp19 (see section 2.27). 
Sequencing of each different insert cloned into the phage vectors (M13mp18 and 
Ml3mp19) was then carried out. The entire sequence of the small 200 bp Bglii-
EcoRI fragment was determined in both directions using just these clones. 
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Fig. ( 3.2 ). 
Restriction endonuclease map of the ilvYC system. 
300 bp 
EcoRI Clai Bgl I I EcoRI EcoRI Kpni EcoRI EcoRI 
Hincii Hinc!I Pvuii Pvu I I 
~---ilvY gene--~ ~----ilvC gene------4 
Fig. ( 3.3 ). 
A. 0. 7% agarose gel electrophoresis of cleaved pGMM201 (lane 2) acting as a size 
control, pP1, pH3 and pH4, which carry ilvYc gene(lanes 3, 4 & 5), digested with 
EcoRI. Lane 1 is .A DNA digested with Pstl. 
The Arrow indicates the position of the ilvY fragment. 
B. Lane 2 and 3 represent digestion of pDUB2400 and pDUB2401 with EcoRI 
plus Bglll. 
Lane 1 is .A DNA marker. 
A 
B 1 
1 2 3 4 5 
2 3 
pUC19 
Large ilvY Fragment 
Small ilvY Fragment 
RESULTS 
3.4 Examination of the ilv Y nucleotide sequences. 
After comparing the nucleotide sequences of the non-transcribed DNA strand 
for the EcoRI-Bglll small fragment from the wild-type and constitutive mutation, 
a single base change was detected between them. The wild type sequence was 
found to be identical to that reported by Wek and Hatfield (1986). This base 
change involves a guanine (G), in position 87 (counted from the transcription 
start point) of the ilv y+ gene, to an adenine (A) transition in the ilv yc mutant 
gene (see Fig.3.4). No additional base changes were observed. This base change 
alters the codon GAA, which codes for glutamine, to the codon AAA that codes 
for lysine in the ilvYc gene (see Fig.3.4). The reading frame remains intact. The 
base change which has been detected in the ilv yc gene is located towards the 5 I 
end. 
No differences between the sequences obtained from the large EcoRI-Bglii 
fragment for either gene or with that found by Wek and Hatfield were observed. 
3.5 Is the single base change responsible for the constitutive pheno-
type?. 
To verify that the base substitution that occurs in the small EcoRI-Bglii 
fragment of the ilv yc mutant gene is totally responsible for making the the gene 
product independent of substrate a-acetohydroxybutyrate or acetolactate for in-
duction of ilvC expression, the following experiments were conducted. 
The first experiment, illustrated in Fig.3.5, involved exchanging the small 
and large EcoRI-Bglll fragments of both wild-type and mutant ilvY genes with 
each other and transforming the reconstructed plasmids into ilvC+ strains in an 
attempt to induce constitutive ilvC gene expression. 
pDUB2400 (ilvYc) and pDUB2401 (ilvY+) were restricted separately with 
EcoRI to generate the ilvY fragments. The total digests were dephosphorylated 
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Fig. ( 3.4 ) 
Nucleotide sequence of the wild-type ilvY gene and the deduced amino acid se-
quence. The base substitution which changes the codon from glutamine to lysine 
in the mutant ilv Y gene is indicated. Location of restriction enzymes cleavage 
sites, ribosome binding site and the transcription start point for either ilvC & ilv Y 
are underlined. 
,[' 
; , .., 
.' ' ~ 
-----EcoRI----
-44 -34 -24 -14 -4 
GAATT CACTATATGA CAGGAAATTT ATTGCGGAAA TTGATATATT 
------
--Hincii--
+1 7 17 27 37 47 
CACAACGTCA CATTGCAATT TTTGCAACGT CAACATCGAG GGCTGTCCCT 
---RBS---
1 10 
GTG GAT TTA CGC GAT CTG AAA ACC TTC CTG 
Met Asp Leu Arg Asp Leu Lys Thr Phe Leu 
AAA Lysine in mutant 
t 
ilvY gene. 
20 
CAT CTG GCG GAA AGC CGC CAT TTT GGC CGC 
His Leu Ala Glu Ser Arg His Phe Gly Arg 
30 
AGC GCG CGG GCG ATG CAC GTT AGC CCA TCC 
Ser Ala Arg Ala Met His Val Ser Pro Ser 
40 
ACG CTC TCA CGG CAG ATT CAG CGC CTG GAA 
Thr Leu Ser Arg Gln I 1 e Gln Arg Leu Glu 
-----Bglii---- - 50 
GAA GAT CTC GGT CAG CCG CTG TTT GTG CGC 
Glu Asp Leu Gly Gln Pro Leu Phe Val Arg 
60 
GAT AAC CGC ACG GTG ACG CTG ACT GAA GCG 
Asp Asn Arg Thr Val Thr Leu Thr Glu Ala 
70 
GGC GAA GAG CTG CGC GTT TTC GCC CAG CAA 
Gly · Glu Glu Leu Arg Val Phe Ala Gln Gln 
80 
ACG CTG TTG CAG TAT CAG CAG TTG CGC CAC 
Thr Leu Leu Gln Tyr Gln Gln Leu Arg His 
90 
ACC ATC GAT CAG CAA GGG CCG TCG CTC TCT 
Thr I 1 e Asp Gln Gln Gly Pro Ser Leu Ser 
100 
GGC GAA TTA CAT ATC TTC TGC TCG GTG ACC 
Gly Glu Leu His Ile Phe Cys Ser Val Thr 
110 
GCT GCC TAC AGC CAT CTG CCG CCG ATT CTG 
Ala Ala Tyr Ser His Leu Pro Pro Ile Leu 
120 
GAT CGC TTC CGC GCG GAA CAC CCG TCG GTG 
Asp Arg Phe Arg Ala Gl u His Pro Ser Val 
130 
GAG ATT AAA CTT ACT ACT GGT GAT GCG GCA 
Glu Ile Lys Leu Thr Thr Gly Asp Ala Ala 
140 
GAT GCG ATG GAA AAG GTG GTC ACT GGT GAA 
Asp Ala Met Glu Lys Val Val Thr Gly Glu 
150 
GCG GAT CTG GCG ATT GCG GGT AAA CCG GAA 
Ala Asp Leu Ala I 1 e Ala Gly Lys Pro Glu 
160 
ACC TTG CCC GGC GCA GTG GCG TTT TCG ATG 
Thr Leu Pro Gly Ala Val Ala Phe Ser Met 
170 
CTG GAG AAT CTG GCA GTA GTG CTG ATT GCC 
Leu Glu Asn Leu Ala Val Val Leu I 1 e Ala 
180 
CCC GCG CTG CCC TGC CCG GTG CGT AAT CAG 
Pro Ala Leu Pro Cys Pro Val Arg Asn Gln 
190 
GTG TCG GTA GAG AAG CCG GAC TGG TCA ACG 
Val Ser Val Glu Lys Pro Asp Trp Ser Thr 
200 
GTG CCG TTT ATT ATG GCC GAT CAG GGG CCG 
Val Pro Phe I 1 e Met Ala Asp Gln Gly Pro 
210 
GTA CGC CGC CGC ATT GAA CTG TGG TTT CGA 
Val Arg Arg Arg I 1 e Glu Leu Trp Phe Arg 
220 
CGC AAT AAA ATC AGT AAC CCG ATG ATT TAC 
Arg Asn Lys I 1 e Ser Asn Pro Met Ile Tyr 
230 
GCC ACG GTT GGC GGG CAT GAA GCG ATG GTA 
Ala Thr Val Gly Gly His Glu Ala Met Val 
-- Clai -- 240 
TCG ATG GTG GCA CTC GGC TCT GGC GTG GCA 
Ser Met Val Ala Leu Gly Cys Gly Val Ala 
250 
TTG TTG CCG GAA GTG GTG CTG GAA AAC AGC 
Leu Leu Pro Glu Val Val Leu Glu Asn Ser 
260 
CCC GAA CCG GTG CGT AAC CGC GTG ATG ATT 
Pro Glu Pro Val Arg Asn Arg Val Met Ile 
270 
TTA GAG CGC AGC GAT GAG AAA ACG CCG TTT 
Leu Glu Arg Ser Asp Glu Lys Thr Pro Phe 
280 
GAG CTG GGC GTG TGT GCG CAG AAA AAG CGG 
Glu Leu Gly Val Cys Ala Gln Lys Lys Arg 
290 
CTA CAT GAG CCG CTA ATT GAG GCA TTC TGG 
Leu His Glu Pro Leu Ile Glu Ala Phe Trp 
297 
AAG ATT TTG CCG AAC CAC AAA TGA CGTTGTCGC 
Lys Ile Leu Pro Asn His Lys STOP 
GCGGGTAGG CCTGATAAG CGAAGCGCT ATCAGGCAT TTTTCCCTA 
ACCCGCCAA AAAGAACCT GAACGCCGG GTTATTGGT TTCGTCGTG 
GCAATCGTA GCCCAGCTC ATTCAGCCG GGTTTCGAA ATCCGGTTC 
ATGGTCGCC AAGTTCGAA CGCCGCCAG TACGCGCCC GTAGTCGGT 
GCCATGGCT CCGATAGTG GAACAAAGA AATGTTCCA GTACGTACC 
CAGCGTGTT GAGGAAGCG CAGCAGCGC GCCCGGTGA TTCCGG 
-- EcoRI--
GAA TTC. 
Fig. ( 3.5 ). 
Scheme for the strategy of the first attempt to verify that the single base change in 
the small ilvY fragment is reponsible for making the ilvC expression constitutive. 
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(see section 2.17) and then restricted with Bglii to generate the small and large 
DNA fragments from each fragment. These DNA fragments were electrophoresed 
and then purified from a low melting point agarose gel (see section 2.16). 
Ligation was now carried out as follows. Firstly, between the small fragment 
(EcoRl-Bglii) of ilvY+ gene and the large fragment (Bglii-EcoRl) of ilvYc. Sec-
ondly between the small fragment of ilvYc and the large one of ilvY+. The two 
ligation mixures were loaded onto a low melting point agarose gel alongside the 
EcoRl ilvY fragment as a size control. The two bands from both ligation mix-
ures which migrated at the same rate as the control DNA fragment were excised 
and purified (see section 2.16). These purified DNA fragments were phosphory-
I 
lated by treatment with T4 polynucleotide kinase in order to generate 5 terminal 
phosphate groups. Then the two phosphorylated fragments were cloned sepa-
rately into the plasmid pUC19 to create new recombinant plasmids pDUB2402 
and pDUB2403 and transformed into JM83 (see section 2.19). 
The screening for recombinant colonies was carried out on L-agar plates con-
taining ampicillin, IPTG and X-gal. A few white colonies appeared from both sets 
of transformation. Mini preparations of plasmid DNA from all white colonies of 
both groups were made (see section 2.25) and the DNA restricted with EcoRl. The 
digested molecules of the two plasmids pD UB2402 and pD UB2403 were loaded 
onto a 0.7% agarose gel alongside an EcoRI ilvY fragment as a control to make 
sure that the two plasmids pDUB2402 and pDUB2403 carry the correct size ilvY 
gene. Unfortunately, none of the recombinant colonies from both experiments 
contained the proper size of ilvY gene fragment (see Fig.3.6A). 
The second experiment involved a different strategy outlined in Fig.3. 7. pDUB2401 
and pDUB2400, that carry the wild type and constitutive ilvY genes respectively, 
were digested with Hindiii plus Bglii. The digested samples were loaded onto a 
low melting point agarose gel, electrophoresed and the two fragments from each 
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Fig. ( 3.6 ). 
A. 0.7% agarose gel electrophoresis ofpDUB2402(1ane 2 to 6) and pDUB2403(lane 
7 to 12) cleaved with EcoRI to show that they have the correct size of reconstructed 
ilvY fragment. Lane 1. EcoRI digested pDUB2400. with the ilvY fragment to 
act as a size control. 
B. Digestion of pDUB2400 and pDUB2401 with Hindiii and Bglii (lane 1 to 4 
& 5 to 7) respectively then electrophoresed on a 0. 7% agarose gel to separate the 
fragments. 
I refers to the large Hindiii-Bglll fragment. 
II refers to the small Hindiii-Bglii fragment. 
C. 0. 7% agarose gel electrophoresis of pDUB2404 and pDUB2405 digested with 
! 
·EcoRI(lane 2 to 7 & 8 to 11 respectively), to examine the correct size of ilvY. All 
the ilvY inserts show an identical migration rate with a size control ilvY fragment 
(III) from pDUB2400(lane 1 ). 
A 
ilvY Fragment 
B 
1 2 3 4 5 6 7 8 9 10 1112 
1234 567 
I 
n 
m 
( 
1 2 3 4 5 6 7 8 9 10 11 
Fig. ( 3.7 ). 
An alternate strategy for verifying that the small EcoRI-Bglii ilvY fragment, is 
solely responsible for the constitutive phenotype. 
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digestion purified (see section 2.16). The large fragment represents most of the 
vector and part of the ilvY gene (EcoRI-Bglii). The smaller fragment represents 
the complementary half of the ilvY gene plus the remainder of the vector (see 
Fig.3.6B). The large and small fragments from each digestion were exchanged and 
ligated. This produces two plasmids containing hybrid ilv Y genes. One contains 
the large EcoRI-Bglll fragment from the wild type ligated to the small Bglii-EcoRI 
fragment from the constitutive gene. The other is the complement of this. 
The two ligation mixures, representing pDUB2404 and pDUB2405, were trans-
formed into JM83 (see section 2.19). Mini-preparations of plasmid DNA from the 
transformed colonies (see section 2.25) and digestion of the DNA with EcoRI fol-
lowed. The digested molecules were loaded onto a 0.7% agarose gel alongside an 
EcoRI ilvY fragment serving as a size control. All of the digested DNA samples of 
pDUB2404 and pDUB2405 showed that they contained the proper reconstructed 
ilvY gene (see Fig.3.6C). 
To proceed further a new selectable marker had to be added to the origi-
nal and new recombinant plasmids. The four plasmids pDUB2400, pDUB2401, 
pDUB2404 and pDUB2405 have a single BamHI site in the pUC19 vector part. A 
BamHI fragment that encodes kanamycin resistance was purified from the plas-
mid pDUB2033 and ligated to the BamHI cut plasmids to create recombinant 
plasmids pDUB2409, pDUB2408, pDUB2407 and pDUB2406. 
The next step involved the transformation of the new plasmids pDUB2406, 
pDUB2407, pDUB2408 and pDUB2409 into CU827(AilvDAYC, Alae) (see sec-
tion 2.19), containing the following individual plasmids:-
pDUB2007 which is RP4::ilvC::lacZ 
pDUB2012 which is RP4::ilvC::lacZ and ilvY::Tn7 
pDUB2013 which is RP4::ilvC::lacZ, ilvY+, Tn7. 
The above plasmids encode ampicillin and tetracycline resistance. Thus, the 
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transformed cells were plated on L-agar plates containing ampicillin , tetracycline 
and kanamycin. The transformed colonies obtained from each transformation set 
were purified on the above agar plates and then transferred to MacConkey agar 
containing lactose in addition to the above antibiotics to examine the inducibilty 
of the ilvC::lacZ fusion. The results are displayed in Table 3.1. 
From the Table 3.1, it is clear that ilvC::lacZ strains that contain pDUB2407 
appear red when they are plated onto the lactose MacConkey agar plates. This 
colony colour is an indication of ilvC inducibility independent of any substrate 
due to the ilvYc mutation carried on pDUB2407. The same colour phenotype was 
obtained for the strains transformed with pDUB2409. The strains that contain 
pDUB2406 and pDUB2408 show white colonies when they are plated on the same 
media. 
3.6 Discussion. 
It is clear from the autoradiograph (see Fig.3.1B) that the degree of hybridiza-
tion to the labelled ilvC fragment is greater to the mRNA extracted from the 
whole-cell lysate of CU962 than to extracts from the other strains. This provides 
evidence that the ilvYc allele, which exists in strain CU962, makes the expression 
of ilvC constitutive due to an increase in the amount of transcription. Strain 
CU152 was included as the wild-type control and shows almost no hybridization. 
Strain CU827 was included as a negative control as it is deleted for the ilvDAYC 
region. In fact the deletion starts within ilvC (Umbarger, H. E., personal com-
munication) and probably fuses ilvC to the ilvGM EDA operon. Thus, message 
complementary to the probe is produced by this strain. A better control would 
have been CU838 which carries the ilv-2049 deletion and lacks all of ilvC. 
Among the three strains used in this experiment no clear hybridized band 
was detected from the RNA species extracted from strains grown in minimal 
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Table (3.1). 
Trans-activation of ilvC::lacZ expression on MacConkey 
agar plates. 
1. pDUB2007 
RP4: :ilvC: :lacz. 
i 1 vY~ 
2. pDUB2012 
RP4: :ilvC: :lacz. 
ilvY::Tn7 
3. pDUB2013 
RP4::ilvC::lacZ, 
il vY~ Tn7. 
pDUB2406 
White 
colonies 
White 
colonies 
White 
colonies 
pDUB2407 
Red 
colonies 
Red 
colonies 
Red 
colonies 
pDUB2408 
White 
colonies 
White 
colonies 
White 
colonies 
pDUB2409 
Red 
colonies 
Red 
colonies 
Red 
colonies 
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media with limiting amounts of isoleucine, leucine. Thus the expected theoretical 
result of no hybridization to CU827; maximal hybridization to CU962 under all 
conditions and CU152 under derepressing conditions; and low hybridization to 
CU152 under repressing conditions was not seen. It is clear that there is higher 
levels of ilvC mRNA in CU962. Fig.3.1A indicates that the total amount of RNA 
isolated from each strain is roughly equivalent. There being slightly more RNA 
from growth in 2x YT media (lanes 3, 6 and 9). If the levels of RNA are roughly 
equivalent then the increased hybridization to CU962 RNA, surely represents an 
increase in the level of transcription of ilvC. However, this increase should also 
have been reflected in RNA extracted from CU962 grown in M9 minimal media. 
It is difficult to state with certainty that upsilon protein acts at the level of 
transcription based on this experiment alone. However, evidence presented later 
indicates that this is indeed the case. 
An investigation was carried out to determine the presice nature of the ilvYc 
mutation. Thus, both ilv y+ and ilv yc were sequenced. The single base change 
which is detected in the nucleotide sequence of ilvYc results in the creation of a 
codon for a different amino acid from that which exists in the wild-type. However, 
the change is fairly conservative substituting a neutral to basic amino acid (glu-
tamine) for a basic amino acid (lysine) (see Fig.3.4 ). The substitution of lysine for 
glutamine in the constitutive upsilon protein makes the protein independent of 
acetohydroxy acid isomeroreductase ( ilvC) substrates ( a-acetohydroxybutyrate 
and acetolactate) in the induction of ilvC expression. Thus, the expression of 
ilvC gene becomes constitutive. 
An amino acid substitution does not always create a phenotypically detectable 
mutation, for instance, a hydrophobic cluster might be virtually unaffected by 
replacement of one leucine by another nonpolar amino acid such as isoleucine. 
Such a conservative change which has no effect on the phenotype is called a silent 
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mutation. Sometimes an amino acid substitution is only partially disruptive, for 
instance, the replacement with a more bulky amino acid such as phenylalanine 
might cause a reduction rather than a loss of activity of an enzyme. Such a 
mutation is called a leaky mutation. On the other hand, in other mutations 
the effect of amino acid substitution is very profound like that which occurs in 
haemoglobin molecules obtained from patients with sickle-cell anaemia, which 
differs from normal haemoglobin only by a single glutamine to valine change in 
the mutant form. 
Two attempts were carried out to verify that the observed change of glutamine 
to lysine in ilv yc is responsible for constitutive phenotype. The first attempt failed 
to obtain the correct size of hybrid ilvY gene cloned into pUC19. Theoretically, 
the strategy for the attempt was correct (see Fig.3.5). The ilvY2143 constitutive 
mutation ( ilv yc allele) is trans-dominant affecting both chromosomes in a partial 
diploid cell. This is a diagnostic feature of positive control. In a cell that contains 
the ilvC::lacZ fusion and ilvYc on the chromosome and ilvC+ on F' plasmid, the 
expression of both enzymes, ilvC-directed ,B-galactosidase and isomeroreductase 
are elevated due to the action of the mutant gene product (Biel and Umbarger, 
1980). 
The second attempt used a different strategy and was successful (see Fig.3.7). 
Four derivative plasmids were produced, pDUB2406 (small ilvY+, large ilvYc), 
pDUB2407(small ilvYc, large ilvY+), pDUB2408 (ilvY+) and pDUB2409 (ilvYc). 
Small and large refer to the two Bglll-EcoRI sub-fragments of ilvY. These four 
plasmids were tested for trans-dominance with a low copy number plasmid carry-
ing the ilvC::lacZ fusion. pDUB2407 and pDUB2409 showed a trans-dominant 
constitutive phenotype. This provides conclusive evidence that the single base 
change that occurs in the small EcoRI-Bglll ilvY fragment is totally responsible 
for making ilvC expression constitutive. 
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4.1 Introduction. 
CHAPTER4 
TRANSCRIPTION OF ilv Y 
RESULTS 
Two group of workers concentrated their studies on determining the direction 
of transcription of the ilv Y C system in different enteric bacteria using different 
techniques. The first group includes Wek and Hatfield (1986) who used E. coli. 
Their studies revealed that the two promoters of ilv Y and ilvC are adjacent and 
transcribed in opposite directions. The other group (Blazey and Burns, 1984), 
used S. typhimurium. Their results were completely different from that of Wek 
and Hatfield. They stated that ilvY transcribes in the same direction as ilvC. 
This chapter provides evidence in support of the results of Wek and Hatfield. 
The direction of ilvY transcription was determined by two approaches. The 
first method involves using a novel technique which is currently widely used to 
study the regulation of gene expression. This technique involves fusing the lacZ 
gene, that encodes ,8-galactosidase, to ilv Y, such that it is under the control of 
the ilvY promoter, and then observing the expression of the lacZ gene. The 
second approach is to express ilvY in a T7 expression system and characterizing 
the labelled products. 
4.2 Fusion of ilvY with lacZ . 
The direction of transcription of ilvY can be determined by making an in 
vitro fusion between the ilvY and lacZ genes, so that the later will be under 
the control of the ilvY promoter. The strategy for this approach is illustrated 
in Fig.4.1. Firstly, the plasmid pDUB2401, containing the wild-type ilvY gene 
was digested with EcoRI and the ilvY containing fragment purified after elec-
trophoresis through low melting point agarose (see section 2.16). This fragment 
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Fig. ( 4.1 ). 
Showing the steps in the construction of the fusion between ilv Y fragments and 
lacZ for the purposes of determining the direction of ilv Y transcription. 
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was ligated to EcoRI cut pBR328 and transformed into JM83. The transformed 
colonies were purified and then screened for resistance to chloramphenicol. Next, 
mini-preparations of plasmid DNA from those colonies which were sensitive to 
chloramphenicol were made (see section 2.25). The presence of the correct ilvY 
fragment was confirmed in the plasmids by restriction with EcoRI (see Fig.4.2A) 
To examine the orientation of the ilv Y gene cloned into pBR328 the plas-
mid DNA from twelve isolates was digested with BamHI and Bglii. The di-
gested molecules were loaded onto 0. 7% low melting point agarose gel and elec-
trophoresed. Two orientations for the ilvY gene are possible in pBR328 (see 
Fig.4.2B). These differ in the position of the ilvY Bglii site with respect to the 
BamHI site of pBR328. The larger Bglii-BamHI fragment of both orientations 
retains most of pBR328, including the ampicillin-resistance gen~. This retains the 
large EcoRI-Bglii ilvY fragment in pDUB2415 and the small EcoRI-Bglii ilvY 
fragment in pDUB2414. The large Bglii-BamHI fragments, from both pDUB2414 
and pDUB2415 were purified from the low melting point agarose gel (see section 
2.16). 
The next step was to purify the lacZ fragment from the pMC1871 (see Fig.4.3). 
The plasmid was digested with BamHI and electrophoresed on a low melting 
point gel (see Fig.4.2C). The lacZ fragment migrates close to the vector fragment 
of pMC1871 so the gel was electrophoresed until the two close fragments sepa-
rated. Next, the lacZ fragment was purified from the gel and ligated separately to 
the large BamHI-Bglii fragments from pDUB2414 and pDUB2415. The ligated 
molecules were transformed into JM83. The cells were plated onto L-agar plates 
plus ampicillin. 
Mini-preparations of plasmid DNA from at least 15 transformed colonies of 
each group were prepared (see section 2.25) and digested with EcoRI to examine 
the orientation of the lacZ gene which must be fused to the ilv Y fragment in 
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Fig. ( 4.2 ). 
A. 0. 7% agarose gel electrophoresis of plasmid DNA from transformed colonies 
sensitive to chloramphenicol cleaved with EcoRI to test the presence of cloned 
ilvY fragment (lane 2 to 10). Lane 1 is pDUB2400 digested with EcoRI to gener-
ate ilv Y fragment acting as a size control. 
B. Two orientations of cloned ilvY fragment with respect to BamHI site on the 
pBR328. 
Lane 1 is .X DNA marker. Lanes 7 to 11 represent one orientation in which the 
large BamHI-Bglll fragment carries the large ilvY sub-fragment (pDUB2415). 
Lanes 2 to 6 show the other orientation in which the large BamHI-Bglll fragment 
carries the small ilvY sub-fragment (pDUB2414). 
C. 0.7% agarose gel electrophoresis of digested pMC1871 with BamHI to generate 
the lacZ fragment. 
A 1 2 3 4 5 6 7 B 9 10 B 1 2 3 4 5 6 7 B 9 10 11 
c 1 2 3 4 
lacZ Fragment 
Fig. ( 4.3 ). 
Restriction map of the fusion vector pMC1871. 
EcoRV 
EcoR I 
8th Amino Acid _ 
BamHI 
Smal 
EcoR I 
BamH I 
Sal I 
Pstl 
pMC1871 
(7460bp) 
BamH I 
Sal I 
Pstl 
BamHI 
Sphl 
Sal I 
Pvu II 
Pst I Sall BamHI EcoR I Sma I 
f ···~pBR322- CT GCA GGT CGA CGG ATC CGG GGA ATT CCC 
8 9 
JamH I PfO vat 
GGG GAT CCC GTC lacZ 
1021 
lys stop stop stop 
AAA TAA TAA TAA CCG GGC 
AGG GG~ GAT CC~ TCG ASC TGC AG,- pBR322 
BamH I Sail Pst I 
RESULTS 
the correct reading frame (see Fig.4.4A & 4.4B). The correct orientation creates 
plasmids with the lacZ EcoRI site adjacent to the BamHI site of pBR328 rather 
than adjacent to the Bglll site of ilvY (see Fig.4.1). 
The plasmid containing pBR328 with the small EcoRI-Bglll fragment of ilvY 
fused in the correct orientation to lacZ was designated pDUB2417 whereas the 
plasmid containing pBR328 with large EcoRI-Bglll fragment of ilvY fused in 
the correct orientation to the lacZ gene was designated pDUB2418. These two 
recombinant plasmids were transformed into the bacterial strain MC4100 (see 
section 2.19) and the cells were plated onto L-agar plates containing ampicillin 
and X-gal as an indicator for lacZ expression. 
All the transformed colonies containing the plasmid pDUB2417 appear blue in 
colour while those containing pDUB2418 were white. Thus, the small EcoRI-Bglll 
fragment of ilv Y definitely contains a promoter region. 
4.3 Expression of ilv Y in the T7 system. 
An alternative method to determine the direction of transcription is to express 
ilvY under the control of a foreign pr01;n.oter, and to determine which orientation 
of ilvY with respect to the promoter gives the correct protein. The system chosen 
was the powerful T7 promoters, which respond only to T7 RNA polymerase. The 
ilvYc gene was expressed in this system (see Fig.4.5). 
The expression of the ilv yc gene in the T7 system involved many steps. 
Firstly, the DNA fragment encoding the ilvYc gene was purified from pDUB2400 
after digestion with EcoRI and then ligated to pGEM-Blue adjacent to the T7 pro-
moter. The ligated molecules were transformed into JM83 (see section 2.19) and 
plated on L-agar plates containing ampicillin, IPTG and X-gal. The white colonies 
were screened for the presence of the inserted ilvY fragment (see Fig.4.6A). 
The cloned ilvY gene in pGEM-Blue could be in either of two orientations 
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Fig. ( 4.5 ). 
lllustrating the two possible orientations of ilvY in pGEM-Blue used in the T7 
expression system to determine the direction of transcription of ilv Y, and secondly 
to obtain high levels of expression of upsilon protein (see chapter 5). 
A 1 2 3 4 5 6 7 8 9 10 11 12 
B 1 2 3 4 5 
Fig. ( 4.4 ). 
A. 0. 7% Agarose gel showing the correct and incorrect fusion of the lacZ fragment 
to the large BamHI-Bglii fragment of pDUB2415 after restriction with EcoRI. 
Lane 1 is A DNA marker. Lane 8 represents the correct fusion of the lacZ fragment 
to the large fragment of ilvY. Other lanes represent the wrong fusion of lacZ 
fragment to the large fragment of ilvY. 
B. BamHI lacZ fragment was fused to the large BamHI-Bglll fragment ofpDUB2414 
then restricted with EcoRI then loaded on a 0. 7% agarose gel. 
Lane 1 is A DNA marker. Lanes 4 & 5 show the correct orientation of lacZ to the 
small fragment of ilvY. Lanes 2 & 3 represent the wrong orientation of lacZ to 
the small fragment of ilvY. 
Fig. ( 4.6 ). 
A. Screening of transformed colonies for the correct ilvY fragment in pGEM-Blue. 
The plasmid DNA from these colonies was digested with EcoRl and loaded onto 
a 0. 7% agarose gel. 
Lane 1 is ilvY fragment from pDUB2400. Lanes 2 to 11 show matching of cloned 
ilv Y fragments with the size control. 
B. Two orientations of cloned ilvY fragment in pGEM-Blue which differ in the 
position of the Bglll site with respect to the T7 promoter. Lanes 2, 3, 6 & 7 
represent the orientation in which the Bglll site of the ilv Y fragment is near the 
T7 promoter. Lanes 1, 4, 5 & 8 is the other orientation in which the Bglll site is 
distal to the T7 promoter. 
A 1 2 3 4 5 6 7 8 9 10 11 
B 12345678 
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with respect to the T7 promoter region (see Fig.4.5). In the first orienation the 
Bglll site of ilv Y is near the T7 promoter and this orientation was designated 
as pDUB2411 (see Fig.4.5). Digestion of this plasmid with BamHI and Bglll 
generates two DNA fragments, one representing the pGEM-Blue plasmid carrying 
the small fragment of ilvYc while the other one is the large fragment of ilvYc (see 
Fig.4.6B). In second orientation the Bglll site is distal from the T7 promoter (see 
Fig.4.5). This orientation was designated as pDUB2412. Thus, ·on digestion of 
this plasmid with Bglll and BamHI, two DNA fragments, one represented pGEM-
Blue carrying the large fragment of ilvY and the second one is the small fragment 
of the gene (see Fig.4.6B). The two orientations were used in a T7 expression 
system to investigate in which direction ilvY is transcribed. 
The two plasmids pDUB2411 and pDUB2412 were transformed separately 
into the strain C600 recA- which also carries pGPl-2 (see section 2.19). The 
cells were plated onto L-agar plates containing ampicillin, kanamycin and IPTG 
and incubated at 30°C for 48 hours. The transformant colonies were purified on 
the same L-agar plates. Thus, two strains were obtained, each has the plasmid 
pGPl-2 and one orientation of the cloned ilvY gene in pGEM-Blue. These strains 
were named as strain A ( contains pDUB2411 and pGPl-2 plasmids) and strain 
B (contains pDUB2412 and pGPl-2 plasmids ). 
Two cultures of strains A and B were inoculated into L-broth plus ampicillin, 
kanamycin and IPTG and then incubated overnight at 30°C. Then, the two cul-
tures were heat shocked at 42°C for 30 minutes, followed, by incubation at 37°C 
for 2-3 hours. 
To determine in which direction ilvY is transcribed, crude extracts were pre-
pared from each strain. This was performed by centrifuging the two cultures and 
resuspend the pellets in 500 J.£1 TE buffer, followed by sonication on ice for 6 x 30 
seconds. The extract was then centrifuged to clarify the solution and remove the 
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cell debris. An equal volume of 2x sample buffer was added and 50 JLl from each 
sample was loaded onto a 10% SDS-polyacrylamide gel (see section 2.13) alongside 
molecular weight protein markers and then electrophoresed overnight at 40 volts. 
The gel was then stained with Coomassie blue, and then destained and dried. 
Many protein bands appeared in the tracks from both strains and the presice 
location of the protein band encoded by the ilvY gene could not be identified (see 
Fig.4.7). 
4.4 Preparation of radiolabelled extracts from strains A and B. 
Preparation of radiolabeled extracts from strains A and B was carried out 
as follows:- Two 10 ml cultures of strains A and B were grown at 30°C for two 
complete days in M9 minimal media containing, 0.5% glucose, 10 JLg/ml thiamine, 
20 J-Lg/ml thymine, 20 JLg/ml threonine, 20 JLg/mlleucine, IPTG, ampicillin and 
kanamycin. The cells were then treated by heat shock at 42°C for 30 minutes in a 
water bath. 1 ml from each strain was taken and 200 JLg/ml rifampicin was added 
to prevent E. coli RNA polymerase transcription of the host. Incubation was 
continued for a further 10 minutes at 42°C then the two samples were transferred 
to 37°C for 20 minutes. Next, 20 JLCi of 835-methionine was added to each sample 
(specific activity 1444 Ci/mmol) and incubated for a further 20 minutes at 37°C. 
Crude extracts were prepared from each radioactive sample as previously de-
scribed and 50 JLl from each sample was loaded onto 10% SDS-PAGE (see section 
2.13) alongside molecular weight weight protein markers. After electrophoresis 
the SDS gel was stained with Coomassie stain and then destained to reveal the 
bands of the protein markers. The gel was then dried and exposed to X-ray film 
for autoradiography. 
Two protein bands appeared in the gel from the extract of strain A, one of 
them is in the molecular weight range of 35000 daltons while the other is smaller 
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of molecular weight 30000 daltons (see Fig.4.8). The 35000 daltons protein band 
represents upsilon protein and the other band is ,8-lactamase protein encoded by 
the ampicillin resistance gene. 
4.5 Discussion 
The ilvYC genes in E. coli K-12 constitute a distinctive regulatory system 
that employs positive control, which is uncommon for biosynthetic genes of amino 
acid operons. In this work the location of the ilv Y promoter was located in 
the small EcoRI-Bglll fragment by using an in vitro fusion technique. Fusions 
vectors were constructed between the two EcoRI-Bglll fragments of ilvY and a 
lacZ fragment which lacks its own promoter and translation initiation site. The 
small EcoRI-Bglll is proposed by Wek and Hatfield to contain the ilvY promoter. 
Their designated reading frame of ilvY means that, if correct, use of the ilvY 
Bglll site will allow the N-terminal end of ilvY to fuse correctly in frame with 
lacZ. The large fragment, if it contains the promoter, has a one in three chance 
of being fused in frame. After transforming these fusions into the bacterial strain 
MC4100 which is deleted for lacZ, cells were plated onto L-agar plus X-gal. 
The expression of the lacZ gene only occurs when MC4100 cells contain 
pDUB2417 in which the small DNA fragment of the ilvY gene was fused to the 
lacZ fragment. This direction of transcription is opposite to that of ilvC. In ad-
dition these results imply that the fusion has occufed in the correct reading frame 
to the N-terminal end of ilvY protein. On the contrary, the appearance of white 
colonies on L-agar plates plus X-gal after transforming MC4100 with pDUB2418 
indicates an absence of a promoter sequence in the large DNA fragment of the 
ilv Y and / or out of frame fusion to a p~otein coding sequence. 
This evidence reported here strongly supports Wek and Hatfield (1986) which 
states that ilvY and ilvC are transcribed in opposite directions. Furthermore the 
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Fig. ( 4.7 ). 
10% SDS-PAGE gel of crude extracts from strains A and B after expressing the 
ilv Y gene in the T7 system. 
Lane 1, 2 & 3 crude extracts from strain A. 
Lane 4, 5 & 6 crude extracts from strain B. 
Lane 7 is standard protein markers. 
Strain A Strain B 
1 2 3 4 5 6 
S. protein markers 
180Kd 
116 Kd 
84Kd 
58Kd 
48.5Kd 
36.5Kd 
26.5Kd 
Fig. ( 4.8 ). 
A. Results of electrophoresis of labelled proteins using 10% SDS-PAGE gel. 
Lane 1 showing two labelled protein bands from strain A, one related to ilvY 
protein (upsilon 35 kd) while the second one is ,8-lactamase ( 30 kd ). 
Lane 2 no labelled protein bands have been detected from strain B. 
Strail Strain 
A B s. protein markers 
-
-
-
-
-
180 Kd 
116 Kd 
84Kd 
58Kcl 
48.5Kd 
36.5Kd 
26.5Kd 
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open reading frame predicted from their DNA sequence, proposed to be the ilvY 
coding sequence, is definitely a translated sequence. Wek and Hatfield used a 
different strategy to verify their predicitions. They determined the in vivo tran-
scriptWal initiation sites of ilv Y and ilvC using S1 nuclease mapping. This tech-
nique involves the extraction of RNA from strains that contain plasmids carrying 
ilvA, ilvC and ilvY fragments. The extracted mRNA was hybridized separately 
to different labelled fragments of the ilv Y C system, Bglii-EcoRl ( -48 to 170 ilv Y) 
and Hincii-Pvull (-75 to 95 ilvC). The hybridized bands were digested with S1 
nuclease and analysed on polyacrylamide/urea gels in parallel with sequence re-
.actions of the EcoRl-Bglii and Hincii-Pvuii DNA fragments. They found that 
the two transcriptional start sites for the genes are 45 nucleotides apart therefore 
they concluded that the two genes are transcribed in the opposite direction. 
Blazey and Burns (1980) studied the ilvYC genes in another enteric bacteriWW' 
S. typhimurium. Their studies included the structural organization of the two 
genes and their regulation. They stated that the ilv Y gene product mediated the 
induction of ilvC expression in a functionally similar manner between E. coli and 
S. typhimurium. Then in 1984 they concentrated their studies on the regulation 
of these two genes in S. typhimurium. They used a galK fusion vector in order to 
determine the direction of transcription of ilvY and ilvC by fusing separately in 
vitro DNA fragments that contain the genes into this vector. After transformation 
the enzyme galactokinase was assayed. They concluded that the ability to promote 
galK expression occurs only when the Xhoi-Sall DNA fragment (encoding ilvY) 
was digested by BAL-31 at the Sail terminus. Thus, the ilvY promoter must be 
located at the Xhol terminus and therefore the ilvY gene is transcribed in the 
same direction as ilvC. 
Both sets of experiments described by Wek and Hatfield (1986) and Blazey 
and Burns (1984) are open to criticism. S1 mapping of mRNA purified from 
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prokaryotes is extremely difficult, due to the difficulties in purifying intact mRNA. 
The fusion studies of Blazey and Burns, produced no supporting evidence. 
Additional evidence on the direction of transcription was added in this work 
through the efforts to radiolabel the upsilon protein after expression in the T7 
system. In the strains A and B the introduction of the ilvYc fragment in both 
orientations under the control of a T7 promoter. A gene for active T7 RNA 
polymerase under the control of the >.PL promoter is carried on pGP1-2. The 
>.cJ857 gene is under the control of the lac promoter on pGP1-2. This promoter 
is induced by inclusion of IPTG in the growth medium, thus allowing expression of 
the>. repressor. At 30°C the heat sensitive>. repressor, does not repress completely 
the initiation of transcription at P L so a terminator for E. coli RNA polymerase 
was inserted into the pGP1-2, so that the expression of T7 RNA polymerase 
from pGP1-2 is dependent on transcriptional readthrough (Tabor and Richardson, 
1985). T7 RNA polymerase was expressed in both strains A and B when the 
cultures were incubated at 42°C. This will inactivate the heat sensitive>. repressor 
which no longer binds to the P L promoter of the T7 RNA polymerase gene. The 
relatively short time for induction is sufficient because even a low level of T7 RNA 
polymerase is enough for initiation of transcription at the T7 promoter on pGEM-
Blue. Transcription initiated at the T7 promoter reads through the cloned ilvY 
fragment. The expression of upsilon protein occurs when the gene is cloned in the 
correct orientation with respect to the T7 promoter. 
Next, labeling of the crude cell extracts from both strains was carried out 
by 835-methionine after inactivation of the host RNA polymerase with rifampicin 
(Chamberlin and Ring, 1973). Since E. coli mRNA decays rapidly, all new mRNA 
in the cell is produced by T7 RNA polymerase. 
From the autoradiograph in (Fig.4.8), it is clear that in strain A a protein 
band of molecular weight approximately 30000 was expressed in addition to the 
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upsilon protein band. This is probably ,8-lactamase which is encoded by the 
ampicillin resistance gene. Neither protein was identified in strain B. In vitro 
studies revealed that the transcription by T7 RNA polymerase from a T7 RNA 
promoter on a plasmid results in transcripts several times the plasmid length 
(McAllister et al., 1981). T7 RNA polymerase is very efficient in transcribing 
the ilvY gene linked next to the T7 promoter in the correct orientation and a 
transcription termination signal seems to be absent. T7 RNA polymerase will 
circumscribe pGEM-Blue several times without terminating and thus transcribe 
the gene for ampicillin resistance as well. 
ilvY is transcribed and translated first. The attachment of ribosomes at ilvY 
may allow the efficient translation of bla as well, as in polycistronic mRNA. When 
ilv Y is inserted in the incorrect orientation no translation occurs as there is no 
sensible reading frame. Ribosomes may find it difficult to initiate translation of 
I 
bla, which is distal from the 5 end of the message (analogous to polar mutations) 
thus accounting for the lack of the 30000 protein band in strain B. Alternatively, 
this non-expressing orientation of ilvY may fortuitously code for an efficient T7 
RNA polymerase transcription terminator. 
The efficient radiolabeling of the upsilon protein has shown that the T7 RNA 
polymerase/promoter system is a successful! alternative procedure for labeling 
plasmid encoded proteins over the mini (Dougan and Sherratt, 1977) or maxicell 
(Sancar et al., 1981) procedures. 
The two pieces of evidence described in this work definitely show that the 
location of the ilvY promoter is located within the small EcoRI-Bglii fragment 
and that ilvY transcription occurs in a direction opposite to that of ilvC, as 
originally proposed by Wek and Hatfield {1986). 
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CHAPTER 5 
Purification and characterization of upsilon protein 
5.1 Introduction. 
This chapter describes the identification and purification of the E. coli DNA 
binding protein, upsilon. Preparation of radioactive upsilon protein was accom-
plished by expression in a T7 based system. Additionally, the native molecular 
weight of the protein was determined by gel filtration. 
The in vitro activities of upsilon protein were examined at the transcriptional 
level and in a cell-free coupled transcription translation system. 
5.2 Purification of upsilon protein. 
pDUB2400 ( ilvYc) was transformed into CU827, which is deleted for ilvDAYC, 
to create strain C which was used as a source of upsilon protein. Strain CU827 
and CU176 (ilvY+) were used as controls. 2litre cultures of CU827, CU176 and 
C were prepared separately in 2x L-broth. The cells were harvested by centrifuga-
tion at 8000 rpm and the pellets resuspended in 10 ml TE buffer. The resuspended 
pellets were sonicated with a medium probe at a pulse rating of 22 for 6 times 30 
seconds on ice. The lysed cells were clarified by centrifugation at 15000 rpm for 
20 minutes at 4 °C. 
The supernatants were retained and made to 1 M N aCl concentration. Then, 
streptomycin sulphate was added at a final concentration of 1% and stirred at 
4°C overnight to remove the nucleic acids. The precipitate was removed by cen-
trifugation for 45 minutes at 15000 rpm at 4°C. 
Then, fractionation of proteins was carried out using ammonium sulphate. 
Various fractions were obtained at 30%, 60% and 90% saturation for each strain. 
To do this the supernatant volume for each strain was determined and the amount 
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of ammonium sulphate to be added to obtain the various fractions was calculated 
from Table 5.1. (NH4)2S04 was added slowly to the supernatants at room tem-
perature with stirring followed by centrifugation for at least 20 minutes at 8000 
rpm and 4°C. The pellets obtained were resuspended in 10 ml TE buffer. 
The three ammonium sulphate fractions of the three strains were dialyzed 
against TE buffer. The dialysis was carried out for 48 hours with 6 to 7 changes 
at 4°C to remove the ammonium sulphate from the protein fractions. 
5.3 Gel retardation assays of the three ammonium sulphate fractions. 
Gel retardation assays were carried out to detect DNA binding activity in the 
three ammonium sulphate fractions. Initially, unlabelled Pvull-Bglll DNA, which 
was purified from pGMM201 (see Fig.3.2 & 5.2B), was used as a substrate. This 
encodes the overlapping region that contains the postulated promoters for ilvY 
and ilvC. The binding reaction was performed as follows:- To 8 eppendorff tubes, 
each containing 1 J.tg of Pvull-Bglll fragment, 1, 2, 3, 4, 5, 6, 7 and 8 J.tg of proteins 
from the 60% ammonium sulphate fraction of strain C, 5 J.tl of lOx binding buffer 
and 2 J.tl of Salmon sperm DNA (5 mg/ml), was added. The reaction samples were 
incubated at 37°C for 20 minutes and the reactions were terminated by adding 
stop dye. Then, the reaction samples were applied to a 1.5% agarose gel alongside 
untreated Pvull-Bglll fragment acting as a control. 
After electrophoresis in TBE buffer the agarose gel was stained in a solution 
containing 0.5 J.tg/ml ethidium bromide and visualized on a UV transilluminator. 
The retardation of the unlabelled DNA fragment gives a good indication of 
the presence of DNA binding activity in the 60% ammonium sulphate fraction 
(see Fig.5.1A). 
The above experiment was repeated, but this time proteins from the 30% and 
90% ammonium sulphate fractions of strain C were used with the same amounts 
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Table 5.1 
Percentage saturation of ammonium sulphate. 
Final concentration of ammonium sulphate, 
% Saturation 
I I I I I I I I I 130 140 150 160 170 lBO 190 11001 
-1-1-1-1-1-1-1-1-1 
Grams solid ammonium sulphate 
to be added to 1 litre of 
solution 
I I I I I I I I I 
Initial concentration 10 I1761243I313I390I472I561I66217671 
of ammonium sulphate 1-1-1-1-1-1-1-1-1-1 
I I I I I I I I I I 130 I I I I19BI273I356I449I5461 
% saturation 1-1-1-1-1-1-1-1-1-1 
I I I I I I I I I I 160 I I I I I 691143122713141 
1-1-1-1-1-1-1-1-1-1 
Fig ( 5.1 ). 
A. Retardation of the unlabelled ilvYC Pvuii-Bglii fragment with the 60% am-
monium sulphate fraction of strain C. Different amounts of proteins {8, 7, 6, 5, 4, 
3, 2, and 1 J.Lg, lanes 2-10). Lane 1 is >. DNA marker. Lane 2 to 9 shows retar-
dation. Lane 10 no retardation occurs. Lane 11 is unlabelled fragment without 
protein. 
B. No retardation could be detected from binding of unlabelled Pvuii-Bglii frag-
ment to proteins from 30% and 90% ammonium sulphate fractions. 
Lane 1 to 3 proteins from 30% fraction. Lane 4 to 6 proteins .from 90% fraction. 
Lane 7 is unlabelled Pvuii-Bglii acting as a size control. 
A 1 2 3 4 5 6 7 8 9 10 11 
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of protein as used above. No retardation was detected in either of the fractions 
(see Fig.5.1B). 
5.4 In vitro transcription of ilvC. 
To examine the activation of ilvC transcription by the three ammonium sui-
phate fractions from strain C, the following quantitative assay was carried out. 
This assay depends on the fact that RNA molecules synthesized in vitro are insolu-
ble in trichloroacetic acid. Thus, in a reaction mixture containing double stranded 
DNA as a template, four nucleotide precursours (ATP, GTP, CTP and UTP) one 
of which was labeled and RNA polymerase, mRNA molecules are synthesized in 
vitro. 
The ilvC Pstl-Bglll DNA fragment was purified from pGMM201 using (see 
Fig.5.2C) using low melting point agarose (see section 2.16). The transcription 
reaction was carried out as follows:- 20 J.Ll Pstl-Bglll DNA (1 J.Lg), 10 J.Ll lOx 
transcription buffer, 10 J.Ll 1 M KCl, 10 J.Ll of nucleotide mixture, 5 J.Ll1f -uridine 
(specific activity 40 Ci/mmol), 2 J.Lg of proteins from each ammonium sulphate 
fraction and 1 J.Ll RNA polymerase (1 unit/ J.Ll) in a total volume of 60 J.Ll. In the 
control sample sterile water was added instead of proteins. The samples were incu-
bated at 37°C for 30 minutes. Then 1.5 ml of 10% trichloroacetic acid was added 
and kept for 10 minutes on ice. The in vitro synthesized RNA was precipited 
on a wet GF /C filter. The filter was then washed with 10 mllO% trichloloacetic 
acid followed by 5 ml absolute ethanol. After drying, the incorporation of labelled 
nucleotides into in vitro synthesized mRNA was measured by liquid scintillation 
counting. 
The results obtained with the in vitro transcription of ilvC, show that max-
imum activity was obtained with proteins from the 30% ammonium sulphate 
fraction, whereas inhibition of transcription occurs when the 60% ammonium sui-
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phate fraction was used (see Table 5.2). This activation was also observed when 
fractions eluted from a DEAE-cellulose column after application of the 30% am-
monium sulphate fraction were assayed (see section 5.6 for method & Table 5.3). 
5.5 Filter binding assays of upsilon protein. 
Filter binding assays were also carried out as an additional procedure for 
the identification of upsilon protein. To perform this assay the Psti-Bglll DNA 
fragment purified from pGMM201 was labelled in vitro by nick translation (see 
section 2.21) to serve as a substrate in the assay. The binding reactions were 
performed as follows:- To 9 tuBes each containing 20 J.tl of labelled DNA fragment 
(specific activity 10x106 CPM/ J.Lg), 30 J.Ll lOx binding buffer, 2 J.Ll of Salmon 
sperm DNA (5 mg/ml) and separately 2 J.Lg of proteins from each ammonium 
sulphate fraction of the strains CU827, CU176 and C. The reaction mixures were 
incubated for 10 minutes at room temperature then applied to wet nitrocellulose 
filters, presoaked in lx binding buffer for 30 minutes. The filters were washed 
with 1 ml of lx binding buffer, then dried and the radiolabelled DNA trapped on 
the filters measured by liquid scintillation counting. 
The filter binding assay, with the 3 ammonium sulphate fractions of strains 
CU827, CU176 and C confirm the result obtained with the gel retardation assay 
(see section 5.3). These measurments show increased retention of labelled DNA 
with proteins from the 60% ammonium sulphate fraction of strai'n C (see Table 
5.4). 
5.6 Purification by DEAE cellulose column chromatography. 
DEAE ( diethylaminoethyl) is a chemically modified cellulose introduced by 
Peterson and Sober (1956). It is an anion exchanger with residues linked to the 
hydroxyl group of the cellulose. 
72 
Table (5.2). 
Sample 
number 
In vitro transcription of ilvC using the 
three ammonium sulphate fractions of strain C. 
Fraction C. P.M. 
1. Control sample 14416 
2. 30% fraction 28039 
3. 60% fraction 2542 
4. 90% fraction 19799 
Table (5.3). 
I 
Fraction 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Control 
sample 
In vitro transcription of ilvC using fractions 
eluted from a DEAE-cellulose column after 
application of the 30% ammonium sulphate fraction 
of strain C. 
C. P.M. 
5156 
7172 
7443 
8350 
13669 
51755 
82543 
8660 
8494 
7099 
Table (5.4). 
Strain 
CU827 
CU176 
Strain C 
Filter-binding assay of ammonium sulphate fractions of 
wild-type, deleted and constitutive strains. 
Ammonium sulphate Readings in 
fraction CPM 
30% 3105 
60% 3471 
90% 5361 
30% 4419 
60% 7619 
90% 1977 
30% 8232 
60% 12154 
90% 7873 
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The basic idea for protein separation through DEAE cellulose columns is the 
formation of multiple electrostatic bonds between the charged sites on the surface 
of the exchanger and sites of opposite charge on the surface of the proteins. In 
addition, non ionic interactions are also formed between the hydroxyl groups of 
the cellulose and the polar residues on the surface of the protein which are mainly 
hydrogen bonds (Tomlinson and Tener, 1963). 
DEAE-cellulose chromatography represents the second stage for upsilon pro-
tein purification. A sufficient amount of DE52 (wet type) was mixed with 20 m1 
TE buffer then the mixure was loaded into the column (16x1cm). After packing 
the column, it was equilibrated with 20 ml TE buffer containing 1.5 M NaCl then 
by 20 ml TE buffer. After equilibration, the ammonium sulphate fractions were 
applied separately to the column. The unbound proteins were washed through 
with 20 ml TE buffer. 
In order to elute bound proteins from the column a stepwise gradient of 10 
ml steps was used. The following buffers of fixed ionic strength were used:- 0.1 M 
NaCl in TE buffer, 0.25 M NaCl in TE buffer and 2M NaCl in TE buffer. 
The fractions eluted from this column were dialyized against TE buffer for at 
least 3 changes at 4°C to remove the NaCl. 
The 60% ammonium sulphate fraction from strains CU827 and C were applied 
separately to the column. Filter binding assays were carried out on the various 
eluted fractions. In this case a significant increase in retained labelled DNA was 
observed when fractions of strain C were compared with the corresponding frac-
tions of CU827 (see Table 5.5). 
5. 7 DNA cellulose column chromatography. 
DNA cellulose chromatography provides selective purification of proteins that 
function on DNA. The most characteristic feature of DNA binding proteins is 
73 
Table (5.5) 
Strain 
CU827 
Control 
sample 
Strain c 
Control 
sample 
Filter binding assays of DEAE-cellulose column fractions. 
The control sample uses sterile water in stead of 
a protein fraction. 
Sodium chloride 
fraction 
0.1 M 
0.25 M 
2 M 
0.1 M 
0.25 M 
2 M 
Readings in 
CPM 
3365 
1061 
3987 
207 
2745 
34155 Duplicate 
39067 sample 
3028 
240 
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their ability to recognize and bind in vitro to any purified DNA under certain 
physiological conditions. 
DNA-cellulose matrix was prepared as follows:- 4g of CFll cellulose was sus-
pended in 12 ml DNA solution containing 8mg of highly polymerized DNA (from 
calf thymus) in TE buffer. The suspended matrix was spread out in a petri dish, 
covered with a gauze and left overnight to dry. The m<lrix was ground to a powder 
and then lyophilized to remove the remaining water. After that the powder was 
suspended in 20 ml TE buffer containing 0.05 M N aCl and the suspension was 
transferred to a column (25xlcm). After packing the column it was washed with 
50 m1 TE buffer containing 0.05 M NaCl. 
The fractions eluted from the DEAE-Cellulose column for strain C which 
contain upsilon protein were mixed and applied to the column after it had been 
made to 0.05 M N aCl. The unbound proteins were washed out with 15 ml TE 
buffer containing 0.05 M N aCl. The bound proteins were eluted by a continous 
gradient consisting of two solutions of 10 ml TE buffer containing 0.05 M and 0.8 
M NaCl respectively. Fractions of 2 ml were collected and dialysed against TE 
buffer with at least 4 changes at 4°C. 
The fractions collected were tested for the presence of upsilon protein by filter 
binding and gel retardation assays using the same procedures described above 
except that the amount of protein sample was 1 j.Lg. 
The gel retardation assay was also carried out using Pvuli-Bglll DNA from 
pGMM201 (see Fig.5.2B). which had been labelled by "filling in" the recessed 3 I 
end (see section 2.22) and polyacrylamide gel rather than agarose gel electrophore-
SIS. 
The fractions eluted from the DNA-cellulose column after applying the active 
DEAE-cellulose fractions from strain C were examined. Particular fractions reveal 
binding activity with the substrate DNA fragment. The clear retardation of the 
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Fig. ( 5.2 ). 
A. 1.5% Agarose gel electrophoresis of pDUB2416 cut with EcoRI & Pvull, and 
EcoRI & HincH to generate two different fragments. These are EcoRI-Pvull 
(100bp) and EcoRI-Hincll (75 bp). 
Lanes 1 & 8 are ,\ DNA marker digested. with Pstl. Lane 2 to 7 pDUB2416 
digested with EcoRI & Pvull. Lane 9 to 12 pDUB2416 digested with EcoRI & 
HincH. 
B. 0. 7% Agarose gel electrophoresis illustrating:-
Lane 1 to 4 pGMM201 cleaved with Pvuii & Bglll. 
C. 0. 7% agarose gel electrophoresis showing:-
Lane 1 is ,\ DNA marker. Lane 2 to 6 pGMM201 cleaved with Pstl & Bglii. 
D. 1.5% Agarose gel electrophoresis showing:-
Lane 1 is DNA marker. Lanes 2 & 3 pDUB2416 restricted with Pvull & Hindi. 
Lanes 4 & 5 pDUB2416 restricted with EcoRI & Pstl. 
B 
A 
EcoRI-Pvu rr~ 
Frogmen 
1 2 3 4 
Pvull-
Bglll 
Frogmen 
c 
1 2 3 4 5 6 7 8 9 10 11 12 
0 
123456 
EcoRI-H incli 
Frogmen 
1 2 3 4 5 
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labelled Pvull-Bglll fragment -in the polyacrylamide gel (see Fig.5.3) provides 
convincing evidence for the presence of upsilon protein in these fractions. 
The measurements of retained labelled DNA fragment in filter binding assays 
using the same fractions that show gel retardation give further evidence that these 
fractions contain upsilon protein (see Table 5.6). 
5.8 Purification of radioactive upsilon protein. 
The protein concentration in the fractions eluted from the DNA cellulose col-
umn using the above methods for purification of upsilon protein is low. To increase 
this concentration an alternative approach was used. This involves expression of 
the ilvYc gene in a T7 system to radiolabel the accumulated upsilon protein. 
Purification was carried out as follows:-. 
A 1 litre culture of strain A (see section 4.3) was grown at 30°C in L-broth 
containing ampicillin, kanamycin and IPTG. This culture was then heat shocked 
at 42°C in a water bath for 45 minutes. Incubation was continued at 37°C for 3-4 
hours to allow the accumulation of upsilon protein. The cells were harvested by 
centrifugation and then frozen at -20°C. During the preparation of the above cells 
a 10 ml culture of the same strain was grown at 30°C in M9 media (see section 
'35" 
4.4), heat shocked at 42°C and then labelled with 200 J.£Ci of s·-methionine. The 
sample was incubated further for 2-4 hours at 37°C. Cells were harvested and 
mixed with those obtained from the 1 litre culture. 
These mixed cells were lysed after suspending in 10 ml of TE buffer using 
sonication at a setting of 22 for 6 times 30 seconds. Next, the lysed cells were 
clarified by centrifugation for 30 minutes at 15000 rpm and the supernatant was 
removed for protein purification. 
The previous steps for purification were followed with slight modifications. A 
continous gradient was used to elute the bound proteins from the DEAE cellulose 
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Fig ( 5.3 ). 
A. Autoradiograph of an 8% polyacrylamide gel for binding of labelled Pvuii-
Bglll DNA to fractions containing upsilon protein eluted from the DNA-cellulose 
column. 
Lane 1 is labelled Pvuii-Bglii fragment acting as a size control. Lane 6 and 7 show 
retardation of the this fragment. Lanes 2, 3, 4, 5, 8 & 9 no retardation occurs, 
these samples use various fractions from the DNA-cellulose column. Lanes 6 & 7, 
use protein from fraction 12 in table 5.6. 
.. 
,., 
Table (5.6). 
Sample 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Control 
sample 
Filter binding assays of DNA-cellulose column fractions. 
The control sample uses sterile water in stead of 
a protein fraction. 
C. P.M. 
51047 
77495 
77508 
64442 
81246 
81879 
72093 
77098 
52218 
53729 
42557 
189749 
90951 
53978 
53248 
57167 
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column rather than a step gradient. This gradient consisted of 2x15 ml solutions, 
the first is TE buffer and the other TE buffer with 1 M N aCl. The detection 
of upsilon protein was carried out by measuring the radioactivty of each fraction 
using liquid scintillation counting. 
The peak fractions eluted from the DEAE-cellulose column which show ra-
dioactivity (see Table 5.7 & Fig.5.4) were mixed and dialyzed against TE buffer 
for at least 4 changes at 4°C. Then, the mixed fractions was applied to a DNA-
cellulose column for the next step of purification. 
The fractions eluted from the DNA-cellulose column were assayed for radioac-
tivity (see Table 5.8 & Fig.5.5) and the active fractions were mixed and dialyzed 
against TE buffer for at least 4 changes at 4°C. This fraction was used for gel re-
tardation assays using various labelled DNA fragments of the ilvYC system and 
to determine the native molecular weight of upsilon protein. 
To examine the purity of the fractions eluted from the DNA-cellulose column 
fractions were subjected to SDS-PAGE and silver staining (see Fig.5.6). 
5.9 Purification of upsilon protein by gel filtration. 
This technique was originally introduced by Porath and Foldin (1959) and is 
used for the separation of protein mixtures by molecular weight. 
Sephadex G-200 was used as the gel matrix due to its particular range of 
molecular weight fractionation. 8g of G-200 (medium grade) was suspended in 
400 ml TE buffer and the gel was left in a boiling water bath for 5 hours to swell. 
Then, the gel suspension was cooled to room temperature and applied to the 
column (70x1.6cm). The packing of the column was carried out overnight using 
TE buffer as an eluant. 
The homogeneity of the gel matrix was checked by applying 1 ml of Blue 
Dextran G-2000 at a concentration of 2 mgjml. Fractions were collected every 2 
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Table (5.7). 
DEAE-cellulose chromatography of labelled upsilon protein. 
Sample C. P.M. Protein concentrations in mg/ml 
number measured at 330 nm 
1 56 0.420 
2 33 0.167 
3 40 0.195 
4 38 0.188 
5 29 0.154 
6 24 0.124 
7 38 0.195 
8 44 0.210 
9 49 0.250 
10 102 1.000 
11 1208 2.375 
12 2677 5.250 
13 2225 4.750 
14 2185 2.125 
15 1622 1.750 
16 1106 1.125 
17 547 0.600 
18 307 0.255 
19 291 0.172 
20 170 0.075 
C. P.M . 
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Table (5.8). 
Sample 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
DNA-cellulose column chromatography. 
C. P.M. 
1286 
741 
419 
273 
252 
199 
155 
148 
125 
119 
109 
799 
280 
270 
306 
275 
120 
C. P.M. 
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SAMPLE NUMBER 
Fig. ( 5.6 ). 
A. 10% SDS-PAGE gel for demonstrating the purity of of peak fractions eluted 
from DNA-cellulose column. 
Lanes 1 & 2 are proteins from the flow through fraction. Lane 3 & 4 are proteins 
from fractions that represent peak activity. 
& 35.5Kd-
S.protein 
mar1kers 
-- il vY protein 
\ 
RESULTS 
minutes and the protein concentration estimated using the Bio-Rad microassay 
method in microtiter plates (Gibco, BRL). The absorbance were measured by a 
Titertek Multiskan MCC plate reader at 595 nm with filter number 8. The void 
volume can be calculated by multiplying the fraction number that shows peak 
absorbance by the fraction volume. 
The next step involved the calibration of the column with particular protein 
markers. Thus, a mixure containing equal concentrations (2 mg/ml) of each of 
the following markers:- Carbonic anydrase (29 kd), Bovine serum albumin (66 
kd), Alcohol dehydrogenase (150 kd) and sweet potato ,8-Amylase (200 kd) was 
applied. The absorbance in the eluted fractions was estimated as described above. 
After determining the elution volume for each protein marker (Vel, Ve2, Ve3 
and Ve4), these elution volumes were divided separately by the void volume to 
obtain the relative mobility for each protein marker. A graph was plotted of the 
log of protein molecular weight against relative mobility in order to construct a 
calibration curve for the column. 
Following the equilibration of the gel filtration column, 1 ml of DNA-cellulose 
purified labelled upsilon protein was applied to the column and fractions collected 
every 2 minutes. After determining the fraction that contains the upsilon pro-
tein by measuring the radioactivity, the elution volume for upsilon protein was 
calculated (Vex) and consequently its relative mobility. 
5.10 Results for gel filtration column. 
After applying the Blue dextran the fractions eluted from the column had 
a volume of 0. 7 ml. Peak of absorbance at 595 nm was obtained with fraction 
number 43 (see Fig.5.7). 
Thus, the void volume of the column= 43 x 0.7 = 30.1 ml. 
The absorbance of the fractions eluted from the column after applying the 
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protein markers showed 4 peaks at fraction numbers 68, 76, 106 and 119 (see 
Fig.5.8). 
The elution volume for the 200 kd protein marker (Vel)= 68 x 0.7 = 47.6 ml. 
The elution volume for the 150 kd protein marker (Ve2)= 76 x 0.7 = 53.2 ml. 
The elution volume for the 66 kd protein marker (Ve3)= 106 x 0.7 = 74.2 ml. 
The elution volume for the 29 kd protein marker (Ve4)= 119 x 0.7 = 83.3 ml. 
These elution volumes for the protein markers (Vel, Ve2, Ve3 and Ve4) are 
divided by the void volume of the column to obtain the relative mobilities. These 
are 1.581, 1.767, 2.465 and 2.767 respectively, which were plotted against the log 
of the molecular weight of the protein markers to obtain the calibration curve (see 
Fig.5.9). 
The radioactively labelled upsilon protein eluted from the column at fraction 
number 64 (Fig.5.10). 
The elution volume for the upsilon protein (Vex)= 64 x 0.7= 44.8 ml. 
The relative mobility for upsilon protein is 1.488 and from the calibration 
curve, the native molecular weight was calculated to be 211.332 kd. From the 
autoradiograph (see Fig.4.8) it is clear that the monomer molecular weight of 
upsilon protein is 35 kd. Thus native upsilon protein appears to be a hexamer. 
Upsilon containing fractions were applied to the SDS-PAGE gel and then 
silver-stained to determine the purity of the fractions (see Fig.5.11 ). 
5.11 Retardation pattern of various DNA fragments of the ilvYC genetic 
system. 
The DNA binding activity of the fractions eluted from gel filtration was exam-
ined with various DNA fragments of ilvYC system. The following DNA fragments 
were labelled by T4 polynucleotide kinase. EcoR1-EcoR1 (135 bp), EcoR1-Pvuii 
(100 bp) and EcoR1-Hincll (75 bp). (See Fig.5.2A & 2D). These DNA fragments 
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Fig ( 5.11 ). 
10%SDS-PAGE gel of peak fractions eluted from gel filtration column to illustrate 
the purity of the upsilon protein. 
Lanes 1 & 3 samples from peak fractions. 
Lane 2 sample from a non-peak fraction . 
1 2 3 S. protein markers 
66Kd 
45Kd 
36Kd 
2 Kd 
14.2 Kd 
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were chosen in an attempt to locate the binding site of upsilon protein. The third 
fragment (EcoRl-HincH) is proposed to contain the overlapping promoter region 
for ilvY and ilvC (Wek and Hatfield, 1986). Retardation was detected only with 
this DNA fragment (see Fig.5.12)and no retardation was observed with the other 
two fragments (see Fig.5.13A & 13B). 
5.12 Examination of the in vitro properties of upsilon protein. 
In order to examine the in vitro properties of upsilon protein, two experiments 
were carried out. Firstly, in vitro transcription of the ilvC gene. 
The in vitro transcription of the ilvC gene was performed as follows:- 6 re-
action samples were prepared, 3 samples used supercoiled DNA of pDUB2416 
containing the entire ilvC gene and part of the ilvY gene (Pstl-Bglll fragment) 
as a template while the remaining 3 used linearized DNA (purified Pstl-Bglll 
fragment) as a template. The first reaction contains the following, 1 Jl.g DNA of 
the plasmid pDUB2416, 10 J.£1 lOx transcription buffer, 10 J.£1 1 M KCl, 10 J.£1 of 
nucleoside triphosphate mixture, 50 J.£Ci om -UTP (40 Ci/mmol) and 1 J.£1 RNA 
polymerase (1 unit/ J-£1). 
The second reaction was identical plus 1 Jl.g upsilon protein from the gel fil-
tration column. 
The third reaction was the same except that upsilon protein was added 12 
minutes after RNA polymerase addition. 
Reaction mixtures 4, 5 and 6 were identical to 1, 2 and 3 respectively except 
using the linear template. 
Reactions 1, 2, 4 and 5 were incubated at 37°C for 20 minutes while the 
reactions 3 and 6 were incubated for 12 minutes before the addition of 1 Jl.g of 
upsilon protein and then incubated for a further 8 minutes. 1.5 ml of 10% TCA 
was added to each sample and placed on ice for 10 minutes. The precipitated RNA 
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Fig. ( 5.12 ) 
Autoradiograph of an 8% polyacrylamide gel of labelled EcoRI-Hincii DNA bound 
to upsilon protein from fractions eluted from gel filtration column. 
Lane 1 is labelled EcoRI-Pvuii fragment acting as a size control. Lane 2 is labelled 
EcoRI-Hincii DNA without upsilon protein. Lanes 3, 4 & 5 are labelled EcoRI-
Hincii DNA bound to upsilon protein. 
1 2 3 4 5 
Fig. ( 5.13 ). 
I • A. EcoRI-EcoRI fragment (135 bp) was 5 end labelled and bound to upsilon pro-
tein from fractions eluted from the gel filtration column, the binding reaction was 
loaded onto 8% polyacrylamide gel, electrophoresed, dried then autoradiographed. 
Lane 1 is the labelled fragment as a size control. Lane 2 shows no retardation 
occurs when this fragment is bound to upsilon protein. 
B. Autoradiograph of binding the labelled EcoRI-Pvuii DNA fragment to upsilon 
protein eluted from the gel filtration column. 
Lane 1 represents the labelled fragment as a size control. lane 2 is the labelled 
fragment bound to upsilon protein, no retardation has been observed. 
N 
....... 
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molecules from each sample were collected onto GF jC filters prewashed with 1 
ml10% TCA. The filters were then washed by 10 ml of 10% TCA followed by 5 
ml absolute ethanol. The filters were dried and the radioactivity counted using 
liquid scintillation. 
5.13 Results for in vitro transcription of ilvC. 
From the measurement of the total number of counts per minute, which rep-
resents the incorporation of labelled nucleotides into RNA, it is clear that the 
addition of upsilon protein eluted from the gel filtration column shows a different 
pattern of activation between using supercoiled DNA and linearized DNA as a 
template (see Table 5.9). The addition of the activator protein at the same time 
as RNA polymerase causes a slight repression of transcription which may be due 
to the competion between the enzyme and the activator for binding to the pro-
moter region. Additionally, the degree of activation of transcription was larger 
with linear template than with supercoiled DNA and only when the activator was 
added 12 minutes after transcription initation. 
5.14 In vitro transcription-translation of ilvC. 
The first reliable method of bacterial cell-free coupled transcription-translation 
was described by Devries and Zubay (1967) and later modified by Zubay (1973) 
and Collins (1979). The cell-free system devised by Zubay involves the prepa-
ration of a crude extract from E. coli which contains all of the enzymes and co-
factors necessary for transcription and translation. In addition the extract must 
be supplemented with amino acids, an energy regenerating system, tRNA and 
nucleotides. 
An alternative method for the preparation of a cell-free coupled transcription-
translation system is described by Gold and Schweiger (1971) which involves the 
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Table (5.9). 
Sample 
number 
1 
2 
3 
4 
5 
6 
0 
In vitro transcription of the plasmid pDUB2416 and the 
linear Psti-Bglii DNA fragment. 
Counts/minute of in vitro 
synthesized RNA molecules 
4211 
4088 
5202 
4127 
3940 
8143 I Duplicate 
I 
8764 
-1 sample 
RESULTS 
fractionation of various components of E. coli with subsequent reconstitution to 
produce an active system. This system has been used as widely as the Zubay 
system. 
As the results of the in vitro transcription of ilvC DNA reveal that upsilon 
protein acts as an activator the following experiment was carried out in an at-
tempt to show this effect in a cell-free coupled transcription translation system. 
The experiment was performed by using a commercial prokaryotic DNA-Directed 
translation kit which is a cell-free coupled transcription-translation system de-
rived from E. coli. An S-30 extract was also prepared from CU827 (AilvDAYC) 
(see section 2.31). The extract from a wild-type E. coli strain MRE600 is already 
found in the kit. 
Constituents of the reaction samples used in these experiments are shown in 
Table 5.10. 
The autoradiograph of the in vitro synthesized proteins using supercoiled 
pDUB2416 as a template (see Fig.5.14), shows that the expression of ilvC was 
detected when using the S-30 extracts from wild type E. coli. However, the addi-
tion of upsilon containing fractions eluted from the DNA-cellulose and gel filtration 
columns did not show any significant increase in the level of ilvC expression. 
The S-30 extract from CU827 showed no expression of ilvC. The addition 
of upsilon protein from the DNA-cellulose and the gel filtration columns to the 
above S-30 extract made no difference and no expression of the ilvC was detected. 
Hence, no significant effect was detected on the expression of ilvC when up-
silon protein was added to S-30 extracts from wild type E. coli and CU827. It is 
probable that the addition of upsilon protein to the wild-type S-30 system could 
not enhance the level of ilvC expression already observed. The protein concen-
tration of the CU827 S-30 may have been too low to be effective. 
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Table (5.10). 
Showing the constituents of various reaction samples 
used in in vitro expression of ilvC. 
I I I 
Sample DNA I Sol. I Sol. Sol. S-35 I S-30 Upsilon 
number template I 2 I 3 5 I methionine! extracts protein 
I I I1444Ci/mmoll 
I I I I 
I I I I 
I I I I 
1. 0 I 7.5 I 3 12 I 20 fLC i I 5 0 
I I I I CU827 
I I I I 
2. + I 5 I 3 5 I 20 fLCi I 5 0 
I I I CU827 
I I I 
3. + I 5 3 0 20 fLCi I 5 7. 5 
I CU827 (from DNA-
I cellulose column). 
4. + 5 3 0 20 fLC i 5 7. 5 CU827 (from gel-
filtration 
column). 
5. + 5 3 5 20 fLCi 5 0 
wild-type 
E. coli 
6. + 5 3 0 20 fLC i 5 7.5 
wild-type (from DNA-
E. coli cellulose 
column). 
7. + 5 3 0 20 fLC i 5 7.5 
wild-type (from gel 
E. coli filtration 
column). 
8. 0 5 3 12 20 fLC i 5 I 0 
wild-type! 
E. coli I 
All the figures in the Table are in microlitres. 
+refers to the presence of pDUB2416 template (1 microgram). 
0 refers to the absence of the constituent. 
Fig. ( 5.14 ). 
A. Autoradiograph of an 10% SDS-PAGE gel of labelled proteins made in a cell 
free coupled transcription and translation system of pDUB2416 (encodes the entire 
ilvC gene). 
Lane 1 represents a control in vitro reaction sample using S-30 extracts from 
CU827 without DNA. Lane 2 in vitro expression ofpDUB2416 using S-30 extracts 
from CU827. Lanes 3 & 4 in vitro expression of pDUB2416 using S-30 extracts 
from CU827 and purified upsilon protein from fraction eluted from DNA-cellulose 
and gel filtration columns respectively. 
Lane 5 in vitro expression of pDUB2416 using the S-30 extracts from wild-type 
E. coli. Lanes 6 & 7 represent in vitro expression of pDUB2416 using S-30 extracts 
from wild-type and purified upsilon protein from DNA-cellulose and gel filtration 
columns respectively. Lane 8 a control in vitro reaction sample using S-30 extracts 
from wild-type E. coli. 

RESULTS 
5.15 Discussion. 
Retardation of the unlabeled Pvuii-Bglll DNA fragment after titrating with 
various amounts of protein from the 60% ammonium sulphate fraction using 
agarose rather than polyacrylamide gels provided the first positive evidence for the 
presence of a DNA binding activity in this fraction (see Fig.5.1A). No retardation 
was detected with the same DNA fragment and the same amount of protein from 
other ammonium sulphate fractions (see Fig.5.1B). 
To Confirm the above results in vitro transcription of the Pstl-Bglll DNA 
fragment was carried out to reveal any activation of transcription of ilvC by the 
various ammonium sulphate fractions. Suprisingly, proteins from the 30% am-
monium sulphate fraction caused a significant apparent activation of ilvC tran-
scription but inhibition of transcription was observed when using proteins from 
the 60% fraction (see Table 5.2). Initially, efforts were concentrated on the 30% 
fraction. This fraction was applied to a DEAE-cellulose column and the fractions 
eluted were used in examining activation of ilvC transcription. Again activation 
was detected in some fractions (see Table 5.3). At this point it was worth using 
another assay system for determining in which fraction upsilon protein occurs. 
This was in an attempt to resolve the discrepancy obtained with the two systems. 
Thus, filter binding assays which are widely used in this field were exploited. 
The Psti-Bglii fragment was labelled in vitro by nick translation and used as a 
substrate. Although, the 60% ammonium sulphate fraction from strain C showed 
an increase in the level of retained labelled DNA (see Table 5.4) compared with 
fractions from other strains, the evidence was not in itself convincing. The 60% 
ammonium sulphate fractions from strains C and CU827 was applied separately 
to a DEAE-cellulose column and the eluted fractions examined for their ability 
to retain the labelled Psti-Bglii fragment. The proteins from the 60% fraction 
of strain C cause excellent retention of the labelled DNA (see Table 5.5). Hence, 
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two assays give a positive result for the presence of upsilon protein in the 60% 
ammonium sulphate fraction of strain C. 
Effort was now concentrated on the 60% ammonium sulphate fraction of strain 
C. This fraction was applied to a DNA-cellulose column which is specific for 
purifying DNA binding proteins. The results obtained from the filter binding and 
gel retardation assays using specific fractions eluted from this column confirm that 
upsilon protein is present in the 60% ammonium sulphate fraction (see Table 5.6 
& Fig.5.3). 
The concentration of proteins in fractions eluted from the DNA-cellulose col-
umn is very low and as large amounts were needed to carry out further experi-
ments, an alternative approach to the purification was investigated. This was to 
express the ilvYc gene in a T7 expression system (for details see section 1.20). 
This type of expression increases the concentration of the protein in the DNA-
cellulose fractions about tenfold so they can be used in subsequent experiments. 
Additionally upsilon protein was labeled so it can be detected easily. 
The proposed location of the ilvC promoter region was confirmed to be in 
the overlapping region of the ilv Y C genes. Fractions that contain upsilon protein 
bind only to the EcoRI-Hincii fragment (see Fig.5.12). This finding supports the 
work of Wek and Hatfield (1986) who proposed that the promoter regions of ilvY 
and ilvC overlap in the small EcoRI-Bglll fragment of ilvY. 
The in vitro behaviour of upsilon protein agrees with the behaviour of other 
purified activator proteins. Lee et al., (1974) studied the in vitro activation of 
transcription of the araBAD operon which requires RNA polymerase, catabolite 
gene activator protein plus the operon specific activator araC. They had provided 
evidence that the araC activator acts in vitro at the level of transcription only. 
Additionally, Arditti et al., (1970) presented evidence for effects of catabolite 
gene activator protein (CAP) and cAMP in vitro. They stated that the transcrip-
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tion of lac genes is stimulated sixfold by CAP and cAMP. This finding supports 
the notion that CAP and cAMP acts to promote expression of lac genes at the 
level of transcription. 
Wild et al .. , (1977) showed that the addition of isomeroreductase substrates 
at the time of adding rifampicin, amino acids and tRNA (at the beginning of the 
translation period) using an ilvC::lacZ fusion as a template had no effect on the 
expression of ,8-galactosidase. The identification of a specific promoter fragment 
to which upsilon binds, the activation of in vitro transcription of ilvC and the 
evidence of Wild et al., clearly shows that upsilon is a true activator protein that 
acts at the level of transcription. 
The failure of expression of ilvC in the presence of the S-30 extract of CU827 
may be due to the lack of the ilvY gene in this strain, so, no upsilon protein 
will be present, and also the low overall protein concenration. Also this strain 
is RNase+ which causes degradation of the in vitro synthesized RNA molecules 
in the coupled transcription translation system. Although, active extracts have 
been prepared from several RNase+ strains including CU827 (Pratt et al., 1981; 
Watson et al., 1979). 
In contrast, E. coli strain MRE600 lacks the major RNase activity of E. coli 
and its S-30 extract is often used for the identification of gene products using a 
plasmid or phage .A as a template. In addition itcontains the wild-type ilvY gene 
and product, so the expression of the ilvC is possible in the presence of inducer 
(see Fig.5.14). However, the expression of ilvC in this experiment occurs in the 
absence of inducer. 
The addition of upsilon protein to both CU827 and wild-typeS-30 extracts 
did not stimulate ilvC expression. This is puzzling as the ilvYc upsilon protein 
purified here, should act to stimulate ilvC expression in trans with the wild-type 
S-30 extracts. (See Fig. 5.14). 
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The appearance of a protein band in the control samples (see Fig.5.14) of 
the wild-type S-30 extract Jere no template DNA was used, may be due to the 
presence of residual DNA in the S-30 extracts which can serve as a template and 
as a result background polypeptides could be expr~ssed. 
Most DNA binding proteins are either dimers or tetramer e.g. CAP is a dimer 
(Decrombrugghe et al., 1984), lac repressor is a tetramer (Gilbert & Muller-Hill, 
1966), .A repressor and cro protein are dimers (Gussin et al., 1983). The finding 
that upsilon protein exists as hexamer in its native state is very unusual. This 
may be a function of binding to two divergent promoters simultaneously. 
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The ilvY and ilvC genes that encode the positive regulatory factor and the en-
zyme acetohydroxy acid isomeroreductase respectively, are adjacent on the E. coli 
chromosome. These genes are transcribed in opposite directions from overlapping 
divergent promoters (Wek and Hatfield, 1986 and this work). ilvC expression 
is under the positive control of a factor (upsilon protein) produced by the ilvY 
gene (Watson et al., 1979). This positive regulatory protein binds to the ilvC sub-
strates ( a-acetohydroxybutyrate or acetolactate) and makes an induction complex 
which is essential for ilvC expression. Thus, in this case the upsilon protein can 
be considered as an auxiliary activator which helps RNA polymerase bind and 
initiate transcription efficiently. 
Mutations have been identified in ilvY which make the expression of ilvC con-
stitutive (Biel and Umbarge( 1980). The product of the ilvYc gene is trans dom-
inant and it is not a repressor in the absence of ilvC substrates. The constitutive 
mutant form no longer needs substrates for induction of ilvC expression. These 
characteristics of the mutant upsilon protein have already been demonstrated by 
Biel and Umbarger (1980). Comparing the above constitutive mutations in ilvY 
with constitutive mutations that occur in other some regulatory genes reveals 
similarity with malTc and araCc mutations. 
The positive control of gene regulation was mainely deduced from the work 
of Englesberg et al., who concentrated their studies on the L-arabinose system of 
E. coli (Englesberg and Wilcox, 1974). 
An example of positive control of gene expression is the ara operon. Mu-
tants strains were isolated that express the araBAD operon constitutively. These 
mutants were classified in two classes, araCc which synthesizes an araC product 
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active even in the absence of inducer (L-arabinose) (Englesberg et al., 1965) and 
araic in which an initatior sequence arai is defined as the site of action of the 
activator. This latter mutation allows the expression of araBAD even in the alr 
sence of araC product (Englesberg et al., 1969; Gielow et al., 1971). The results 
obtained after introducing the araC+ allele into strains carrying the above consti-
tutive mutations to create merodiploid strains and growing them in medium free 
from arabinose, were unexpected. The constitutive expression produced by these 
mutations was repressed in these merodiploid strains (Englesberg et al., 1969). 
Thus, the araC+ allele was shown to repress the constitutive phenotype resulting 
from an aracc or araic mutation. They concluded that the araC product is a 
repressor in the absence of inducer (L-arabinose) and an activator when inducer 
is present. 
The maltose regulon in E. coli is believed to positively regulated. malT pro-
tein is the activator for the malPQ, malK and malEFG operons (Schwartz, 
1967a; Hofnung, 1974). Mutants have been isolated which express these three 
operons constitutively (Debarbouille et al., 1978) by using a strain in which the 
lac operon is fused to the malPQ operon. Some of these mutations are located 
in the positive regulatory gene and called malTc. In these mutants the modified 
malTc is still active i.e. it has the ability to stimulate the expression of the mal 
operon even in the absence of maltose in the media. Debarbouille et al., (1978) 
characterized this malTC product by constructing merodiploid strains after intro-
ducing the malT+ allele into malTc strains. malTc mutations are trans dominant, 
which is characteristic of positive control. They concluded that the malT+ allele 
does not result in the repression of constitutive expression and as a result the 
malT+ product is not a repressor in the the absence of inducer (maltose). Thus, 
this constitutive mutation in malTc shows similar characteristics with that of the 
ilv yc mutation. Both of them encode products which are trans dominant and are 
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not repressors in the absence of inducer. 
ilvYC is one of a few positive regulatory systems that have been described in 
E. coli. It is unique in being part of an amino acid biosynthesis operon. From the 
DNA sequence of the EcoRl-Hincii region which contains the promoter regions 
of both ilvY and ilvC (see Fig.6.1), it is clear that the -35 regions of both pro-
moters overlap. This creates a direct repeat sequence separated by 6 nucleotides. 
From the above information the mechanism of positive control via upsilon protein 
can be described, with some modifications, according to two models proposed to 
interprete the mechanism of positive control of .X repressor. 
The first mechanism depends on the alteration in the intracellular upsilon 
protein concentration. So, at high concentration of upsilon protein, a dimer (2 
monomer subunits bind together to form a dimer which comprises the DNA-
binding form) will recognize the direct repeat sequence in the EcoRl-Hincll DNA 
fragment and bind to it. This bound dimer occupies the repeated sequence and 
directs RNA polymerase to bind at the -10 region of the ilvC promoter. This 
direction of RNA polymerase by bound upsilon protein is enhanced not just by 
DNA-protein interactions but also by protein-protein interactions. In this situ-
ation the RNA polymerase recognizes the -10 region of the ilvC promoter more 
efficiently than that of the ilvY gene because the -10 region of the ilvY gene might 
be covered by the bound upsilon protein as it is nearer to the repeated sequence 
than that of ilvC by three base pair (see Fig.6.1). Thus, the TATA box of ilvC 
promoter is more accessible to RNA polymerase. Simultaneously, the bound up-
silon protein represses transcription initiation at the TATA box of the ilvY gene 
and consequently ilvY expression is negatively autoregulated. 
How does ilv Y expression occur?. The answer according to this model is 
as follows:- In the case of a low concentration of upsilon protein there will be 
insufficient to form dimers and fill the direct repeat sequence. The ·._-_ RNA 
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Fig. ( 6.1 ). 
B. Nucleotide sequence of the EcoRI-Hincii fragment of ilvY gene showing the -10 
regions of the ilvYC genes, direction of transcription and the repeated sequences 
which are proposed to be the binding sites for upsilon protein. 
EcoRI 
+1 
GAATT CACTATATGA 
-10 Sequence 
of ilvC. 
ilvC Transcription 
+1 
CACAACGTCA CATTGCAATT 
ilvY Transcription 
CAGGAAATTT ATTGCGGAAATT 
I 
Repeated sequence 
Hincii 
TTTGCAACGT CAAC. 
GATATATT 
-10 Sequence 
of ilvY. 
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polymerase has a greater affinity for the ilvY promoter than the ilvC promoter. 
So, it will bind and initiate transcription of ilv Y. 
Thus, the following conclusions can be made. The transcription of the ilvY 
. 
and ilvC genes occurs in a retproc:-al manner depending on the intracellular con-
centration of upsilon protein. The upsilon protein exerts both activator (of ilvC) 
and repressor (of ilv Y) functions when it binds to the repeated sequences. 
An alternative model can be proposed to demonstrate the mechanism by which 
upsilon protein causes induction of ilvC expression. This model depends on the 
fact that due to the proximity of the ilvY and ilvC promoters, there will be 
competion for RNA polymerase by the two promoters. RNA polymerase prefers 
··t:. 
to bind to the ilvY promoter. This binding, which stimulates ilvY expression, 
will prevent ilvC expression, perhaps by steric hindrance. But in the presence of 
upsilon protein, it will stimulate binding of RNA polymerase to the ilvC promoter 
rather than to the ilvY promter. 
However, it must be emphasised that both of the preceeding models of upsilon 
function are difficult to reconcile with a native protein that is a hexamer. It is 
possible that the mode of action of upsilon is much more complex, like the ara 
operon or like A repressor protein (see below). DNA footprinting studies will be 
needed to firmly establish the exact location and number of upsilon binding sites. 
The proposed mechanisms of upsilon protein action can be compared with the 
mechanisms of other regulatory proteins. 
The major known regulatory protein which is an activator is catabolite gene 
activator protein (CAP). It plays an important role in the regulation of many 
operons, e.g., lac, gal and mal. This regulatory protein is activated by cAMP. The 
mechanism by which this complex activates transcription is not known exactly. 
Two models have been proposed, firstly the binding of this complex to DNA 
sequences upstream of the -35 region activate lac transcription by increasing the 
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binding constant of RNA polmerase i.e. RNA polymerase is attracted not just 
by DNA-Protein interactions but also by Protein-Protein interactions. Secondly, 
it could be that the cAMP-CAP complex acts at a distance by changing the 
structure of the DNA near the RNA polymerase binding site. 
Some regulatory proteins can autoregulate their own production (Smith and 
Magasanik, 1971). In S. typhimurium, the degradation of the amino acid his-
tidine is performed by two sets of enzymes encoded by separate operons. Each 
operon has its own promoter-operator. A single repressor binds to both opera-
tors and prevents transcription in the absence of histidine (Smith and Magasanik, 
1971 ). In the presence of histidine the repressor binds histidine, dissociates from 
the operators and allows transcription to initiate in both operons. It is worth 
mentioning here that the repressor molecule synthesis is under control of histidine 
as well because it is encoded by a gene in one of the two operons. When histi-
dine is scarce free repressor molecules accumulate which switch off the synthesis 
of more repressor. Thus, the synthesis of repressor is controlled by itself and the 
regulation comprise a negative autogenous regulation. 
Two regulatory proteins play contrasting roles in determining the mode of 
growth of bacteriophage A. These are A repressor and cro which are encoded by 
the genes ci and cro repectively. A repressor is required for lysogeny while cro 
protein for lytic phage growth. The ability of A to grow in two alternate modes, 
lytically or lysogenically, depends upon the interaction of the regulatory proteins 
with three contiguous binding sites which are identified in the right operator on 
the A chromosome. These are OR1, OR2 and OR3. 
In lysogeny, the repressor is bound predominately to OR1 and OR2 but rarely 
at OR3. This binding leads to the repression of lytic genes, including cro, from the 
promoter P R which overlaps with ORl. The transcription of ci from the promoter 
P RM is stimulated by repressor bound to OR1 and OR2. These two effects of the 
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repressor are essential to maintain the lysogenic state. In addition, the repressor 
has another function, binding to 0 R3 represses expression from P RM in order 
to autoregulate its synthesis. Thus, this regulatory protein can autoregulate its 
expression both negatively and positively. 
Ptashne et al., (1980) analyized the mechanism by which repressor can repress 
at PR and stimulate at PRM when it bound to OR2. Sequence analysis has 
revealed that the two promoters P R and P RM, overlap an 82 bp region defined as 
the right operator. OR2 is closer to the transcription start point of P R than that 
of P RM by one base pair. They believe that this slight difference in position allows 
repressor to touch RNA polymerase bound to PRM and to exclude it from PR. 
Thus, according to this hypothesis the repressor directly stimulates transcription 
from PRM possibly by directing protein-protein contact with RNA polymerase so 
stabilizing its binding or increasing its frequency of initiation of transcription. 
An alternative model has been proposed to describe the mechanism of positive 
control by the .A repressor. This model holds that the stimulatory effect is a 
result of the small distance ( 82 bp) between the transcription startpoints of P R 
and PRM· The competing polymerase model holds that RNA polymerase binds 
preferentially to PR and inhibits binding of RNA polymerase to PRM perphaps 
by steric hindrance. The role of the repressor is to stimulate P RM binding simply 
by preventing binding of polymerase to P R (Meyer and Ptashne, 1980). 
Meyer and Ptashne (1980) provided evidence to support the first model by 
analyizing the activity of various mutants. They showed that the ability of repres-
sor to activate gene transcription is not a consequence of the proximity of the two 
.A promoters. Moreover, polymerase bound at P R has little negative effect on the 
basal level of transcription at P RM and that neither removal of P R nor exclusion 
of RNA polymerase from P R by another regulator ( cro) suffices to activate P RM, 
therefore they concluded that the ability of repressor to activate gene transcrip-
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tion is not a trivial consequence of the proximity of the two A promoters, rather, 
repressor activates P RM directly. 
In contrast to repressor the cro protein permits lytic growth by first binding 
to OR3 and so repressing synthesis from PRM· As its concentration increases it 
will bind to OR2 and OR1 thereby turning off transcription from PR (Johnson 
et al., 1978; Meyer et al., 1980). Thus, the cro protein action is less complex 
than that of repressor. It is strictly a negative regulator because it represses the 
transcription from P RM and also turns off expression of its own and other lytic 
genes from P R. 
From the description above it is clear that the A repressor does not require 
cofactors to stimulate the ci gene transcription, unlike CAP and upsilon protein. 
An additional positive regulatory protein found in the bacteriophage A is N 
protein. This regulatory protein turns on genes to the left of N including ci I I 
and the recombination genes and genes to the right of cro including ci I and the 
DNA replication genes 0 and Q. N protein works by enabling RNA polymerase to 
transcribe through DNA that would otherwise cause mRNA synthesis to terminate 
and is therefore is called an anti-terminator. The mechanism of N protein action 
is still unclear. But it is known that this protein recognize a specific sequence 
called NUT (N-utilization ). There are two nut sites, one between P L and the 
N gene and the other just to the right of the cro gene. The action of N protein 
is as follows. In the absence of N protein RNA polymerase ignores the nut site 
and dissociates from the DNA releasing mRNA when it reaches the transcription 
termination signals. But in the presence of N protein, which bind to the nut sites, 
as RNA polymerase passes over a nut it will be modified by N protein so that it 
will ignore certain but not all further termination signals. 
The most complex positive regulator in bacteria, is araC protein in the L -
arabinose operon system. This operon is under the control of two activators, the 
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araC and CAP proteins. The promoter region contains more than one activator 
binding sites. This was suggested by Englesberg and Wilcox (1974) who stated 
that the araBAD promoter includes two activator binding sites, one for araC 
protein and the other for CAP. 
Later, groups of workers concentrated their studies on how these two activators 
function. (Ogden et al., 1980; Lee et al., 1981). For araC protein three binding 
sites have been identified. These are arai, ara01 and ara02, the latter is distal 
from the promoter regions of the araBAD and araC (Dunn et al., 1984; Hahn 
et al., 1984). ara01 overlaps with the araC promoter. This overlapping leads to 
repression of the araC expression when the araC protein is accumulated in the 
cell. As a result of this araC expression is autoregulated. The role of the other 
binding sites arai and ara02 is to cooperate with the binding site for CAP to 
mediate the activation and repression of the araBAD operon. 
Many models have been postulated to interprete the mechanism of activation 
of araC and BAD promoters. One of these proposes that at low concentrations of 
CAP the araC protein binds to two binding sites arai and ara02 and as a result 
of this binding, draws the DNA into a loop. The formation of this loop represents a 
repressing configuration so that the a raG protein cannot activate RNA polymerase 
to initiate transcription at the araBAD promoter whether arabinose is bound to 
it or not, and at the same time repression of the araC promoter occurs. 
On the other hand, the presence of cAMP-CAP at high levels will allow it 
to bind to its site which is located next to arai. This changes the araC protein 
conformation by touching it such that araC protein is no longer able to form 
the loop but will release the DNA at ara02. In the meantime it activates RNA 
polymerase to initiate transcription at the araBAD promoter and also repress the 
araC promoter. The only possible way for araC protein to promote activation 
of araBAD expression is to bind to arabinose first. Thus, for efficient expression 
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of araBAD two molecules are required. These are cAMP-CAP and arabinose. 
a raG promoter is activated when there is no a raG protein as in this case RNA 
polymerase can binds to the araC promoter which overlaps ara01 and initiate 
transcription. 
A positive regulatory system also exists for the regulation of some genes in-
volved in the biosynthesis of lysine. Straiger et al., (1983a) identified the lysR 
gene and determined its exact location. lysR is closely linked to lysA and encodes 
an activator protein which is necessary for full expression of lysA. lysA is the 
structural gene code for the enzyme diaminopimelate decarboxylase (DAP). The 
two genes lysA and lysR are transcribed divergently. This organization is similar 
to that in araC-araBAD (Wilcox et al., 1974) and ilvC-ilvY (Wek and Hatfield, 
1986). Additionally, Straiger et al., (1983b) presented evidence that lysA is under 
the positive control of the product of lysR and lysR protein represses expression 
of its own gene. Thus, the activator protein encoded by lysR has dual effects. 
Straiger and Patte (1983) concentrated their studies on the molecular mech-
anism of this positive control. They examined the nucleotide Sequence of lysA-
lysR. The two ATGs for the lysA and lysR proteins are separated by 121 bp. 
They identified a 73 bp fragment carrying the promoter, first four codons and the 
information necessary for autoregulation of lysR. The same binding site could be 
involved in both effects of the lysR product, acting simultaneously an operator 
for lysR expression and an initiator for lysA. 
Models for the mechanism of activation of transcription by positive control are 
really much more difficult to formulate than those for negative control. Repressor 
proteins in negative control function primarily by preventing RNA polymerase 
binding at promoters. Activation by positive control could occur by stimulating 
either the binding or the isomerization of RNA polymerase, or by blocking com-
peting RNA polymerase binding sites. Alternatively, the necessity for an auxiliary 
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protein for the activation of gene transcription might be related to the deviation 
of the positively controlled promoter sequences (-35 and -10 regions) from the 
promoter consensus sequence. So, these promoters require a protein which helps 
RNA polymerase binding to the promoter region. A third possibility for positive 
control is to function as a transcription antiterminator, like .A N protein. Finally 
positive control factors have also been shown to act as RNA polymerase a (sigma) 
subunits which cause polymerase to recognize whole new classes of promoters. 
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